hg_175986.1

Basic information about the TSS

---

TSS ID: hg_175986.1 Species: human Chr: chr19		Start: 41302703 End: 41302721 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000595806.1 AK021455 Distance: -311 GeneID: 11100 HGNC/MGI_ID: HGNC:17011 UniProt_ID:

Gene_name: heterogeneous nuclear ribonucleoprotein U like 1 Gene_symbol: HNRNPUL1 Gene_synonyms: E1B-AP5 E1BAP5 FLJ12944 Gene_source: HGNC:17011

TATA-Box annotation

---

Distance to TSS:	-7460
Nearest PromoterID:	NM_052848
Entrez ID:	90324
Nearest Unigene:	Hs.437497
Nearest Refseq:	NM_052848
Nearest Ensembl:	ENSG00000142039
Gene Name:	heterogeneous nuclear ribonucleoprotein U like 1
Gene Alias:	-
Gene Description:	coiled-coil domain containing 97
Gene Type:	protein-coding
CpG%:	0.035
GC%:	0.552239
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):	76(CCCCTGAAAAGC,-,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HNRNPUL1 p2@HNRNPUL1 p3@HNRNPUL1 p5@HNRNPUL1 p6@HNRNPUL1 p7@HNRNPUL1 p9@HNRNPUL1
Sample		p1@HNRNPUL1	p2@HNRNPUL1	p3@HNRNPUL1	p5@HNRNPUL1	p6@HNRNPUL1	p7@HNRNPUL1	p9@HNRNPUL1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	59.03	17.34	5.84	5.26	17.34	8.96	2.53
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	74.66	19.83	5.06	9.51	19.83	8.30	2.23
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	63.27	18.52	6.17	9.26	21.99	14.66	2.31
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	55.51	16.42	3.74	4.37	17.88	7.90	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	56.24	17.55	5.85	7.20	22.05	6.30	1.80
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	50.97	16.09	6.40	5.43	19.19	7.75	1.55
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	84.76	18.08	5.23	6.32	16.56	12.42	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	61.52	25.68	6.78	5.33	21.80	7.99	2.42
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	71.60	18.17	4.70	8.76	20.94	9.83	3.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	54.48	21.45	5.22	5.22	23.19	4.06	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	51.74	21.83	1.62	5.66	22.64	8.08	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	43.91	22.36	2.44	4.88	25.21	4.88	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	56.42	9.03	4.67	3.06	0.81	10.16	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	49.47	6.01	6.01	3.46	0.75	5.56	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	56.64	6.59	4.83	2.20	0.88	5.27	1.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	51.56	8.55	5.78	3.27	1.01	11.32	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	43.90	5.02	4.37	2.18	0.22	6.77	1.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	54.41	5.91	3.80	2.11	0.00	16.45	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	45.85	8.00	6.40	1.60	0.00	6.93	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	49.80	6.32	5.57	4.66	0.90	9.03	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	53.33	6.42	5.61	3.74	0.67	9.62	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	47.13	5.35	4.66	3.80	1.04	8.29	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	46.40	5.69	5.17	2.33	0.78	5.95	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	51.20	5.34	5.82	2.43	0.49	7.77	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	46.95	4.90	4.64	1.55	0.77	8.51	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	49.06	3.48	5.70	3.48	1.27	6.65	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	42.31	4.40	3.30	1.65	0.55	9.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	51.87	8.25	4.72	2.83	0.94	5.89	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	48.13	7.91	4.20	3.88	0.97	10.01	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	45.24	5.79	4.52	3.62	2.53	7.96	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	38.10	5.23	3.35	2.51	0.84	8.37	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	42.59	6.25	3.13	2.74	1.56	8.40	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	49.38	4.22	3.17	3.17	0.84	13.29	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	46.18	7.26	5.11	3.46	1.15	9.24	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	40.95	6.73	5.80	1.87	0.93	11.41	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	40.43	5.37	4.02	2.30	0.57	7.86	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	42.72	4.91	4.70	5.31	1.23	9.61	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	39.49	5.64	3.83	2.62	1.61	6.65	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	56.72	7.56	4.32	2.16	0.00	11.88	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	40.33	6.48	5.28	2.64	0.72	6.48	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	38.58	6.12	5.41	2.59	0.47	7.76	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	38.79	7.91	6.15	3.07	0.59	6.59	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	40.28	6.54	2.74	2.95	0.84	6.96	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	43.71	6.12	3.50	2.45	0.70	12.06	0.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	40.56	5.62	5.22	2.81	1.41	4.62	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	44.90	5.58	5.12	2.79	1.16	7.68	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	35.75	7.20	5.52	2.40	0.96	7.20	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	43.81	6.86	7.75	2.38	1.49	10.43	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	36.38	6.22	4.07	3.35	1.44	7.90	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	38.62	9.10	5.66	3.64	0.81	7.68	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	41.61	8.61	6.35	4.10	1.84	9.43	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	46.70	8.89	7.56	4.00	2.00	14.23	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	55.97	13.99	13.99	0.00	27.98	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	34.42	7.81	4.26	2.13	1.42	7.10	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	34.80	8.62	4.97	2.65	0.99	8.95	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	46.98	20.13	29.36	1.68	3.36	16.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	39.49	11.48	9.18	4.13	2.76	18.83	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	32.73	7.45	6.48	2.27	0.65	11.67	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	27.30	7.39	3.21	0.96	2.25	7.71	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	36.46	12.57	11.94	4.40	1.26	21.69	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	26.09	7.76	7.05	6.35	0.00	8.46	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	30.28	4.49	3.93	2.24	2.24	5.05	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	27.07	5.57	24.68	3.98	1.59	23.88	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	27.52	7.14	8.83	4.42	1.02	16.65	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	26.64	7.80	4.22	3.25	0.32	12.67	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	29.11	4.97	6.39	2.84	1.06	9.94	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	80.82	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	55.28	0.00	78.97	0.00	0.00	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	33.15	8.78	6.34	0.00	0.98	5.85	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	39.67	4.96	4.96	2.98	1.98	5.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	25.33	5.16	3.28	2.35	0.94	1.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	34.44	3.31	5.96	2.98	0.99	9.60	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	29.08	3.09	3.71	0.62	2.47	7.42	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	33.94	4.89	4.89	3.06	1.83	5.81	0.00
Adipocyte - breast, donor1	11376-118A8	33.26	9.03	3.17	1.90	1.90	1.58	0.48
Adipocyte - breast, donor2	11327-117E4	30.80	15.56	6.10	2.41	1.12	1.76	0.48
Adipocyte - omental, donor1	11473-119C6	31.55	7.51	3.56	2.29	1.78	0.89	0.13
Adipocyte - omental, donor2	11474-119C7	26.91	8.97	2.24	0.75	0.75	2.99	0.00
Adipocyte - omental, donor3	11475-119C8	31.82	10.38	2.68	2.01	0.33	1.00	1.00
Adipocyte - perirenal, donor1	11476-119C9	27.43	8.29	3.83	1.28	1.28	2.55	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	12.09	2.20	1.10	1.10	0.00	2.20	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	17.16	4.97	6.32	0.90	1.35	1.35	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	35.97	9.04	2.09	2.09	2.61	0.87	1.04
Adipocyte differentiation, day04, donor1	13019-139D4	58.08	14.08	5.48	3.52	1.37	0.98	1.76
Adipocyte differentiation, day04, donor2	13022-139D7	40.67	16.73	6.18	2.06	0.51	1.03	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	48.23	11.15	4.18	2.79	1.39	1.12	2.79
Adipocyte differentiation, day04, donor4	13028-139E4	50.55	19.40	8.23	4.70	1.76	0.00	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	41.34	16.33	4.67	2.73	2.33	0.48	1.37
Adipocyte differentiation, day08, donor2	13023-139D8	44.22	12.59	3.87	1.61	2.26	1.94	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	34.66	16.00	4.27	1.60	0.53	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	46.74	11.13	3.34	1.11	3.34	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	27.03	7.49	0.42	2.91	1.25	1.25	1.25
Adipocyte differentiation, day12, donor2	13024-139D9	19.34	10.05	2.51	1.51	1.00	1.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	28.14	10.80	2.62	0.65	0.98	1.31	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	25.88	15.22	0.91	0.91	0.61	0.61	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	55.47	19.67	19.67	3.09	6.63	2.43	3.31
Alveolar Epithelial Cells, donor2	11590-120G6	53.07	21.51	12.55	3.94	4.66	2.15	3.59
Alveolar Epithelial Cells, donor3	11671-122G6	35.94	9.58	9.58	3.59	1.20	0.00	3.59
Amniotic Epithelial Cells, donor1	11533-120A3	68.72	15.29	10.97	4.14	2.52	2.70	1.98
Amniotic Epithelial Cells, donor2	11613-122A2	70.29	13.39	6.69	1.67	3.35	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	59.17	11.71	8.22	3.29	1.85	2.67	2.88
Anulus Pulposus Cell, donor1	11248-116E6	60.19	10.98	5.15	3.32	0.92	1.95	1.60
Anulus Pulposus Cell, donor2	11463-119B5	61.47	13.47	6.12	3.43	0.24	1.47	0.98
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	28.31	12.58	6.29	0.45	1.35	3.59	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	32.56	9.99	6.51	1.30	1.30	3.04	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	8.56	8.56	0.00	2.14	4.28	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	30.19	11.36	4.48	0.90	0.60	1.49	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	30.35	11.38	6.32	1.26	0.00	5.06	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	14.52	7.26	1.32	0.66	0.00	3.96	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	27.29	8.45	3.90	0.97	0.32	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	34.95	11.17	5.34	0.00	1.46	1.46	1.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	16.63	8.91	5.94	1.19	0.59	4.75	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	24.86	7.16	6.03	1.51	1.51	2.64	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	29.75	17.42	5.81	0.00	2.18	2.18	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	16.30	3.76	2.51	0.00	2.51	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	20.59	7.08	2.47	1.81	0.49	0.33	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	34.12	8.19	1.36	0.00	0.00	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	16.59	4.22	3.77	2.11	0.00	0.60	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	27.33	10.18	5.36	1.61	1.07	2.14	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	25.32	7.94	4.72	1.89	0.76	1.51	1.51
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	19.78	9.09	5.35	0.53	1.60	2.14	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	34.14	2.93	5.85	0.98	0.98	3.90	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	27.37	9.45	6.14	1.82	1.33	2.65	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	22.81	4.80	3.60	1.20	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	7.08	3.54	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	28.30	6.35	7.20	2.23	0.34	2.06	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	0.00	0.00	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	24.76	8.74	6.80	1.94	0.97	4.85	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	25.42	7.97	7.59	2.66	0.76	2.66	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	18.17	8.48	1.21	0.00	2.42	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	21.09	9.69	3.99	1.71	0.57	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	26.08	7.48	5.99	0.43	0.43	2.14	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	27.36	7.23	3.61	1.29	0.77	0.77	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	31.44	10.79	5.16	1.41	0.94	3.28	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	28.62	8.04	5.47	0.64	1.61	1.61	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	22.12	6.42	4.28	2.14	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	28.66	6.43	5.26	1.75	1.75	3.51	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	27.40	5.72	4.82	1.20	0.60	2.11	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	26.14	10.69	2.38	0.00	1.19	3.56	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	30.01	9.66	5.09	1.02	0.51	5.09	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	21.90	10.70	7.64	3.06	0.51	4.08	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	17.79	5.72	1.27	0.64	0.00	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	31.50	9.06	6.90	2.59	0.43	3.45	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	23.07	6.99	3.81	2.12	0.21	2.75	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	19.43	5.80	2.61	0.29	1.16	1.74	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	40.62	8.50	1.89	1.89	0.00	5.67	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	25.26	6.44	4.07	2.54	1.02	1.36	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	27.80	9.27	0.00	2.32	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	42.25	6.34	8.45	0.00	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	34.52	6.86	5.36	1.72	0.64	1.07	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	19.85	4.81	4.21	0.60	1.20	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	28.43	4.37	8.02	2.92	0.73	3.64	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	24.14	8.51	5.29	2.99	1.15	1.61	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	10.20	7.65	0.00	0.00	12.75	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	14.75	3.81	3.81	1.78	0.76	1.02	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	27.66	7.64	7.43	2.06	1.03	1.86	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	23.56	6.12	2.45	0.92	1.22	1.22	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	32.50	10.52	6.69	0.96	1.43	4.30	1.91
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	26.61	5.54	7.98	2.00	0.44	2.00	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	21.36	1.53	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	26.03	10.52	3.32	1.11	1.11	3.32	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	20.92	7.94	6.62	2.12	1.06	3.18	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	17.45	6.91	3.63	2.54	0.36	1.09	0.00
Astrocyte - cerebellum, donor1	11500-119F6	115.94	21.49	13.14	5.77	7.00	2.82	9.58
Astrocyte - cerebellum, donor2	11580-120F5	117.07	25.33	8.73	10.27	4.45	3.25	6.85
Astrocyte - cerebellum, donor3	11661-122F5	62.29	17.20	3.57	2.31	3.36	1.68	4.40
Astrocyte - cerebral cortex, donor1	11235-116D2	82.96	14.29	7.32	7.67	3.83	3.14	6.27
Astrocyte - cerebral cortex, donor2	11316-117D2	96.90	26.05	8.09	5.34	5.99	5.99	3.72
Astrocyte - cerebral cortex, donor3	11392-118C6	86.21	20.73	7.46	6.71	5.07	4.47	3.73
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	102.30	65.26	13.65	2.18	7.23	5.16	3.10
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	105.86	58.38	18.04	3.51	7.52	3.13	3.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	96.39	58.26	15.25	1.82	7.06	3.30	2.16
Basophils, donor1	12241-129G9	99.12	36.61	1.05	5.75	0.26	1.57	0.78
Basophils, donor2	12242-129H1	124.11	33.91	2.16	6.13	2.16	0.36	1.08
Basophils, donor3	12243-129H2	104.37	24.99	1.32	6.61	0.44	1.03	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	31.91	11.64	3.67	1.29	1.94	1.29	3.02
Bronchial Epithelial Cell, donor2	11591-120G7	48.00	13.72	3.20	1.83	0.91	1.83	3.20
Bronchial Epithelial Cell, donor3	11672-122G7	21.52	0.00	0.00	0.00	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	32.64	24.48	5.02	2.51	2.51	1.26	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	54.28	27.87	9.98	1.87	4.37	0.62	3.12
Bronchial Epithelial Cell, donor6	11461-119B3	43.76	17.73	6.22	1.15	3.45	0.69	2.53
Bronchial Epithelial Cell, donor7	11769-123I5	27.71	14.58	4.32	1.44	0.90	2.88	2.16
Burkitt's lymphoma cell line:DAUDI	10422-106C8	136.96	33.08	1.13	6.60	3.19	3.81	4.64
Burkitt's lymphoma cell line:RAJI	10476-106I8	85.48	45.42	2.10	2.56	3.96	5.82	7.69
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	79.62	17.91	4.16	7.35	1.28	0.32	6.08
CD133+ stem cells - cord blood derived, pool1	12223-129E9	103.42	20.68	0.00	10.34	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	81.15	19.72	0.00	2.25	0.56	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	109.69	46.59	0.56	3.16	1.30	3.16	0.19
CD14+ Monocytes, donor3	11381-118B4	86.06	28.32	0.88	4.61	0.66	2.20	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	78.97	20.66	2.26	3.96	1.13	1.70	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	60.27	15.16	2.65	3.79	0.76	1.14	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	75.28	28.93	3.29	3.29	0.00	1.31	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	86.30	29.34	1.45	2.31	0.43	4.48	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	75.74	22.33	1.81	1.51	0.00	2.72	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	87.89	31.27	1.66	1.90	0.47	1.66	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	67.46	19.75	1.00	2.51	0.67	1.34	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	51.34	17.11	0.83	0.28	0.28	1.93	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	52.56	19.34	0.74	1.98	0.25	1.74	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	52.87	15.47	1.17	1.17	0.20	1.76	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	62.50	17.63	0.36	2.14	0.53	1.60	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	51.80	20.46	0.65	0.65	0.22	1.09	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	55.49	14.98	1.64	1.17	0.47	1.64	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	74.98	29.57	0.53	1.06	0.00	1.06	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	66.56	32.17	2.22	4.44	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	73.63	25.14	1.49	2.23	0.74	3.57	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	56.67	20.75	1.60	1.80	0.60	1.80	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	44.55	20.40	1.87	2.50	1.04	0.83	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	56.05	21.05	0.46	2.52	1.37	2.52	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	49.54	16.51	1.36	2.26	1.58	0.23	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	40.59	20.08	0.87	1.75	1.31	1.75	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	73.70	19.91	0.81	2.69	0.81	3.23	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	78.86	23.73	1.05	2.44	0.35	2.09	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	85.85	25.67	0.42	1.68	0.42	1.26	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	45.74	12.86	0.55	1.10	0.18	1.84	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	46.15	11.98	0.70	0.70	0.00	0.70	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	34.22	17.11	0.88	0.44	0.00	1.75	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	55.80	16.91	1.74	1.22	0.17	2.62	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	68.39	18.96	1.12	0.74	0.37	2.60	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	59.49	19.83	0.86	1.94	0.00	1.08	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	46.27	11.47	0.82	2.46	0.41	1.64	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	45.43	12.75	0.70	1.39	0.46	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	36.89	10.21	0.23	0.70	0.46	1.62	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	34.00	31.17	0.44	0.00	0.87	1.09	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	46.43	30.95	0.23	0.23	0.46	1.39	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	26.64	16.25	0.43	1.08	0.00	0.43	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	70.07	44.85	0.16	1.09	0.16	1.25	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	68.11	30.21	0.35	0.87	0.17	2.45	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	101.01	67.34	1.34	2.01	0.45	1.78	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	25.77	16.59	0.00	0.51	0.00	0.51	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	37.33	29.64	0.44	0.22	0.00	1.32	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	25.69	18.32	0.00	0.00	0.21	0.84	0.84
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	50.81	22.36	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	51.53	27.80	0.68	3.39	0.00	1.36	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	75.60	23.82	0.00	1.04	0.00	0.00	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	50.11	22.92	0.53	0.53	1.07	1.60	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	71.83	46.64	0.00	2.14	0.00	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	53.35	28.08	0.70	1.40	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	54.90	27.45	0.00	0.00	0.78	0.78	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	63.28	18.46	0.00	1.32	1.32	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	95.34	50.96	0.00	2.47	0.00	4.93	4.11
CD19+ B Cells, donor2	11624-122B4	89.95	52.23	0.73	4.35	0.73	2.90	2.90
CD19+ B Cells, donor3	11705-123B4	99.45	46.44	0.00	4.04	1.01	3.53	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	144.25	72.73	0.81	2.42	4.85	4.44	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	101.07	58.73	0.40	2.00	6.39	3.99	0.40
CD34+ Progenitors, donor1	11545-120B6	74.30	6.02	2.01	2.01	2.01	0.00	3.01
CD34+ Progenitors, donor2	11625-122B5	80.90	15.73	0.56	10.11	1.69	0.00	1.69
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	75.90	14.28	3.01	5.64	0.75	1.50	5.26
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	89.74	21.65	2.93	5.64	2.03	0.45	4.06
CD4+ T Cells, donor1	11225-116C1	192.10	22.85	3.21	14.28	2.50	3.21	1.07
CD4+ T Cells, donor2	11306-117C1	180.65	39.19	4.90	9.80	5.51	12.86	1.84
CD4+ T Cells, donor3	11382-118B5	142.43	33.55	5.18	8.54	3.35	6.71	2.44
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	85.76	52.07	3.57	1.53	1.02	2.55	2.55
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	90.06	29.87	2.02	1.35	0.22	2.47	2.70
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	87.96	30.18	2.30	2.01	0.86	1.44	2.01
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	69.22	29.87	1.90	3.32	4.27	0.00	5.22
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	92.00	26.69	0.70	4.21	0.70	1.40	3.51
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	85.70	19.78	0.00	3.30	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	100.15	48.27	6.21	3.32	1.59	3.90	2.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	84.56	40.84	2.88	3.39	1.53	5.59	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	73.99	22.89	2.58	1.93	1.29	7.42	1.29
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	65.00	34.97	0.00	3.59	0.45	1.79	2.69
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	83.15	23.06	0.35	2.80	0.00	4.54	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	78.76	38.28	2.20	2.64	0.44	3.52	2.64
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	101.19	51.02	4.22	2.11	1.26	5.48	3.37
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	80.61	29.09	4.57	3.95	1.45	8.73	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	75.85	24.06	2.34	2.00	0.00	6.35	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	108.50	42.15	0.82	2.45	0.54	3.54	3.81
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	142.03	42.88	0.54	5.36	0.00	0.54	5.90
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	82.49	28.69	0.00	1.79	3.59	3.59	5.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	125.53	58.04	5.01	3.52	2.23	3.34	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	97.48	35.31	5.85	3.90	1.30	5.85	0.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	115.16	36.78	6.09	5.67	0.84	3.99	1.89
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	71.80	29.33	3.54	3.54	2.53	0.00	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	100.08	22.96	4.33	3.90	2.60	1.30	1.73
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	91.09	41.84	6.10	3.49	1.31	3.92	2.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	103.92	30.19	0.49	2.97	0.99	0.00	2.47
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	102.47	20.31	1.85	2.77	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	73.98	23.73	2.79	2.79	0.00	0.00	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	143.17	39.88	2.49	2.77	1.38	1.38	6.65
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	167.36	48.59	2.94	4.17	2.21	1.96	6.63
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	106.26	36.96	4.62	3.08	0.00	0.00	4.62
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	104.21	34.38	3.94	2.51	1.07	1.07	5.01
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	114.95	26.31	1.38	1.38	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	148.97	18.01	2.95	15.06	2.62	2.62	2.29
CD8+ T Cells, donor2	11307-117C2	152.80	36.04	3.00	11.64	2.63	9.39	0.75
CD8+ T Cells, donor3	11383-118B6	158.31	35.60	4.54	9.85	6.31	5.55	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	23.86	25.46	6.88	1.38	6.88	5.51	2.06
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	24.44	25.88	6.95	1.44	5.51	5.27	1.68
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	24.62	25.17	6.29	0.55	3.83	2.74	2.19
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	20.41	31.52	8.71	0.60	4.80	5.10	4.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	28.32	26.88	6.96	2.16	5.04	4.32	2.16
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	25.47	25.69	5.68	0.45	3.64	3.64	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	17.17	24.12	10.21	0.43	10.00	2.17	1.30
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	23.16	25.00	8.42	0.53	8.42	7.90	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	23.92	29.31	10.55	0.47	8.68	3.99	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	24.45	26.87	7.55	1.81	6.94	6.04	2.42
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	31.08	30.21	4.36	0.87	2.61	6.39	2.03
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	19.45	31.17	9.59	1.87	4.53	2.40	1.87
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	20.57	26.27	7.00	1.31	2.63	0.88	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	21.41	24.14	6.38	3.19	3.19	1.82	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	26.11	23.87	6.71	0.75	0.75	0.75	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	21.61	32.05	11.52	1.08	5.76	5.04	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	22.15	23.59	8.92	0.86	4.60	2.30	3.45
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	24.75	23.81	7.78	0.47	4.01	1.89	1.65
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	21.87	31.69	14.58	1.27	6.97	1.58	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	21.53	26.14	13.23	1.23	7.38	3.08	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	23.72	25.65	18.27	0.96	8.01	3.85	2.89
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	19.12	26.77	4.97	0.76	7.27	1.91	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	20.10	22.46	5.12	0.00	4.73	4.73	1.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	21.18	28.74	3.03	0.00	3.78	3.78	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	16.06	28.91	2.41	0.80	4.01	2.41	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	22.38	28.68	2.10	0.00	2.80	2.10	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	22.04	28.05	7.01	2.00	2.00	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	91.39	20.11	10.97	3.66	1.83	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	40.52	13.83	6.92	0.99	0.00	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	29.25	7.37	5.47	2.84	1.58	0.63	1.37
Chondrocyte - de diff, donor1	11261-116G1	45.07	8.32	5.55	2.43	5.20	7.97	1.04
Chondrocyte - de diff, donor2	11338-117F6	47.98	7.11	6.04	3.20	0.71	1.07	1.42
Chondrocyte - de diff, donor3	11410-118E6	32.88	7.51	2.62	2.39	0.68	4.78	0.46
Chondrocyte - re diff, donor2	11339-117F7	85.05	24.17	4.48	8.06	1.79	0.90	2.69
Chondrocyte - re diff, donor3	11411-118E7	59.85	12.94	5.26	5.26	0.81	1.62	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	75.17	16.98	8.84	4.48	2.64	2.64	3.44
Ciliary Epithelial Cells, donor2	11323-117D9	46.60	10.90	6.63	3.21	3.21	3.42	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	59.74	16.90	8.14	6.02	3.10	3.01	2.74
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	97.48	31.64	3.67	4.13	0.83	2.29	1.83
Corneal Epithelial Cells, donor1	11526-119I5	39.74	15.81	5.93	2.20	4.39	0.88	2.85
Corneal Epithelial Cells, donor2	11606-120I4	35.27	36.40	1.14	1.14	1.14	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	40.65	24.28	4.86	1.53	3.32	2.30	2.56
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	31.86	13.04	2.64	0.66	0.33	0.66	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	39.43	14.51	2.21	2.21	0.00	0.95	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	34.51	6.90	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	30.45	13.71	1.84	0.86	0.22	2.05	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	172.87	16.06	7.52	9.91	2.39	2.73	2.39
Dendritic Cells - plasmacytoid, donor2	11309-117C4	147.55	19.59	7.83	11.10	1.96	0.00	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	163.57	19.84	8.71	12.58	1.45	1.45	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	66.04	23.35	7.50	8.67	5.67	0.00	3.00
Endothelial Cells - Aortic, donor1	11263-116G3	47.53	15.26	9.98	7.63	6.45	0.00	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	58.82	20.36	6.50	9.05	2.83	2.26	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	65.27	18.87	6.29	8.65	5.90	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	36.07	13.38	6.11	3.78	2.04	2.62	0.87
Endothelial Cells - Artery, donor2	11341-117F9	58.35	29.41	4.71	6.59	6.35	2.35	3.06
Endothelial Cells - Artery, donor3	11413-118E9	54.87	30.33	11.22	7.89	6.49	1.05	2.10
Endothelial Cells - Lymphatic, donor1	11236-116D3	44.33	8.64	3.55	9.53	0.89	0.66	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	41.68	10.65	3.04	6.69	0.61	0.61	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	46.80	10.15	1.97	10.15	0.85	1.97	2.54
Endothelial Cells - Microvascular, donor1	11265-116G5	42.19	14.26	4.16	6.54	2.38	2.38	2.08
Endothelial Cells - Microvascular, donor2	11342-117G1	35.93	8.85	8.85	4.69	5.73	0.52	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	43.39	11.48	3.12	5.25	1.99	0.85	1.28
Endothelial Cells - Thoracic, donor1	11266-116G6	55.62	25.61	8.80	7.60	5.60	3.60	4.00
Endothelial Cells - Thoracic, donor2	11343-117G2	37.74	12.05	5.77	3.67	4.72	3.14	1.57
Endothelial Cells - Umbilical vein, donor1	11243-116E1	96.54	33.55	5.47	13.79	5.22	2.11	1.99
Endothelial Cells - Umbilical vein, donor2	11324-117E1	86.69	34.54	2.17	12.82	3.69	2.82	2.17
Endothelial Cells - Umbilical vein, donor3	11400-118D5	86.47	38.71	3.91	11.11	5.37	1.34	3.05
Endothelial Cells - Vein, donor1	11267-116G7	42.09	10.24	9.10	5.69	7.96	0.00	2.28
Endothelial Cells - Vein, donor2	11344-117G3	48.90	15.37	7.68	4.19	9.08	2.10	3.49
Endothelial Cells - Vein, donor3	11416-118F3	64.84	19.63	8.95	8.79	3.61	1.57	2.04
Eosinophils, donor1	12244-129H3	121.98	45.74	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	267.34	75.91	3.30	8.25	0.00	6.60	0.00
Eosinophils, donor3	12246-129H5	164.07	71.34	0.00	10.70	0.00	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	36.89	8.55	4.40	1.71	2.44	0.98	1.71
Esophageal Epithelial Cells, donor2	11587-120G3	29.12	18.72	4.16	4.16	0.00	4.16	6.24
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	16.27	0.00	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	39.82	9.85	2.87	2.87	1.64	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	10.40	3.72	1.20	0.88	0.44	3.83	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	44.20	12.35	2.49	3.36	2.82	15.28	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	51.06	12.86	7.16	4.12	4.49	3.27	2.06
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	10.51	3.96	4.09	1.91	0.27	0.55	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	37.44	8.75	4.85	2.43	2.21	3.27	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	29.25	9.22	3.95	1.32	1.32	1.84	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	51.49	14.62	5.32	5.65	3.65	3.99	1.00
Fibroblast - Cardiac, donor1	11268-116G8	37.65	12.70	8.62	2.27	2.72	1.81	0.91
Fibroblast - Cardiac, donor2	11345-117G4	56.85	17.43	7.58	3.79	0.76	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	21.92	7.57	4.89	3.63	2.68	1.42	0.32
Fibroblast - Cardiac, donor4	11452-119A3	58.80	14.85	10.31	4.24	1.52	0.61	0.91
Fibroblast - Cardiac, donor5	11456-119A7	53.81	17.26	4.31	4.70	1.40	2.16	2.03
Fibroblast - Cardiac, donor6	11460-119B2	49.27	17.58	8.64	3.94	2.43	1.52	1.06
Fibroblast - Choroid Plexus, donor1	11492-119E7	63.65	23.05	9.92	3.75	4.29	2.14	5.49
Fibroblast - Choroid Plexus, donor2	11572-120E6	41.85	27.18	6.04	2.59	2.59	0.86	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	38.08	23.44	7.32	2.93	5.86	1.46	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	98.02	23.29	8.99	6.23	8.76	2.54	4.38
Fibroblast - Conjunctival, donor3	11692-122I9	70.22	13.40	4.24	2.20	1.53	3.39	2.20
Fibroblast - Dermal, donor1	11269-116G9	20.43	7.04	4.93	1.88	2.35	0.94	0.23
Fibroblast - Dermal, donor2	11346-117G5	44.34	19.81	13.21	5.19	9.91	0.00	2.36
Fibroblast - Dermal, donor3	11418-118F5	25.02	7.86	4.84	1.33	1.57	4.35	0.12
Fibroblast - Dermal, donor4	11450-119A1	67.15	28.71	4.86	3.96	4.30	2.03	5.09
Fibroblast - Dermal, donor5	11454-119A5	91.94	31.23	6.63	5.41	4.01	3.14	4.54
Fibroblast - Dermal, donor6	11458-119A9	88.68	32.65	6.98	4.71	5.36	2.92	5.85
Fibroblast - Gingival, donor1	11237-116D4	58.72	13.12	5.83	5.00	2.29	0.21	1.25
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	73.88	25.15	11.00	4.19	1.57	1.57	0.26
Fibroblast - Gingival, donor2	11318-117D4	76.70	19.50	6.85	5.80	5.53	3.95	0.66
Fibroblast - Gingival, donor3	11394-118C8	69.32	16.73	4.16	4.25	1.55	0.77	0.87
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	51.94	3.12	7.27	5.19	2.08	0.00	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	38.76	11.63	2.29	2.82	1.94	2.11	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	104.92	24.94	13.87	7.33	6.24	4.99	1.25
Fibroblast - Gingival, donor6 (control)	11922-125H5	70.99	18.39	7.98	4.73	5.68	5.41	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	50.81	12.70	6.70	6.35	6.00	1.06	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	80.58	16.82	7.75	5.26	5.41	5.41	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	86.58	23.18	9.27	5.18	6.68	4.09	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	92.25	26.77	10.64	6.25	7.46	4.17	0.66
Fibroblast - Gingival, donor9 (control)	11927-125I1	69.55	12.03	4.40	2.49	1.17	2.93	1.17
Fibroblast - Lung, donor1	11270-116H1	31.27	14.95	10.87	4.08	1.36	0.00	4.08
Fibroblast - Lung, donor2	11347-117G6	73.12	16.41	16.41	5.97	5.97	4.48	2.98
Fibroblast - Lung, donor3	11419-118F6	55.29	16.25	6.54	5.06	2.32	2.53	1.27
Fibroblast - Lymphatic, donor1	11506-119G3	144.95	41.65	22.49	12.50	9.16	0.00	2.50
Fibroblast - Lymphatic, donor2	11586-120G2	54.55	13.99	4.20	2.80	1.40	1.40	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	30.51	10.92	4.48	1.96	1.96	0.56	0.56
Fibroblast - Mammary, donor1	11540-120B1	129.10	33.29	26.39	5.28	14.21	1.62	4.87
Fibroblast - Mammary, donor2	11620-122A9	55.92	15.98	7.99	0.00	7.99	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	17.87	0.00	29.78	0.00	0.00	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	79.14	18.62	8.53	4.66	4.27	2.72	2.91
Fibroblast - Periodontal Ligament, donor2	11319-117D5	106.78	37.77	5.16	8.65	8.04	4.40	2.88
Fibroblast - Periodontal Ligament, donor3	11395-118C9	85.37	14.99	11.63	10.71	6.43	0.61	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	87.39	12.98	4.96	6.11	1.91	2.29	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	55.35	13.23	5.94	2.97	2.70	3.78	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	51.96	13.34	4.06	2.44	1.39	1.28	1.04
Fibroblast - Pulmonary Artery, donor1	11250-116E8	28.96	11.50	8.07	3.09	2.21	1.11	0.88
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	75.99	24.59	26.01	5.69	9.75	2.03	3.86
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	80.85	22.72	9.35	1.34	4.68	2.00	2.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	40.33	10.67	1.19	3.56	0.79	3.16	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	43.86	12.90	8.53	1.98	3.97	5.56	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	40.67	8.88	4.26	1.24	1.07	1.95	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	43.36	9.85	11.23	1.77	1.77	2.76	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	33.39	15.95	9.93	3.01	1.81	2.71	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	77.29	15.11	12.52	7.02	4.32	2.16	1.62
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	24.04	10.38	9.11	0.25	0.76	4.05	1.01
Fibroblast - skin normal, donor1	11553-120C5	43.64	9.52	8.04	1.64	1.80	2.13	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	38.30	10.83	14.04	3.01	2.61	2.21	2.01
Fibroblast - skin normal, donor2	11561-120D4	64.30	20.80	10.15	4.52	3.21	2.41	2.61
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	45.34	15.41	13.90	1.21	1.21	5.44	3.63
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	49.13	9.78	8.20	2.32	1.16	1.33	0.99
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	90.77	14.87	14.70	5.64	1.54	1.71	1.37
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	29.56	9.85	8.21	0.66	3.28	1.31	1.97
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	69.24	17.68	10.12	4.79	2.98	2.77	2.34
Fibroblast - skin walker warburg, donor1	11554-120C6	66.29	13.66	14.34	7.42	3.88	4.22	1.18
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	33.56	9.57	7.53	2.51	1.88	11.92	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	132.96	0.00	88.64	22.16	22.16	22.16	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	54.03	28.76	2.61	0.00	0.87	2.61	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	20.98	10.05	9.71	1.39	2.43	0.87	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	29.15	10.41	8.33	2.34	2.34	2.60	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	33.73	11.24	9.96	4.09	3.83	1.02	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	59.71	18.37	3.06	3.06	11.48	10.72	4.59
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	55.51	17.87	5.74	0.64	12.76	4.47	5.10
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	60.19	17.69	5.71	6.85	9.13	12.27	5.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	78.04	14.06	5.52	3.31	1.10	12.96	3.58
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	67.13	14.84	1.83	3.42	0.91	6.85	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	57.26	15.06	3.17	3.37	3.57	9.51	5.55
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	65.56	12.95	2.91	3.70	2.38	8.72	2.91
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	63.27	18.26	5.22	3.91	1.63	2.94	3.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	48.64	21.23	3.98	6.19	6.63	15.92	4.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	58.51	12.30	6.92	3.53	6.78	6.08	5.65
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	68.22	16.50	6.77	3.94	3.69	4.56	7.02
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	52.65	16.65	7.25	2.69	6.98	3.22	6.18
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	59.22	12.64	10.90	4.58	3.47	5.45	4.58
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	54.26	16.89	12.87	4.43	4.71	3.74	4.29
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	50.62	12.60	9.76	2.85	3.66	5.49	2.64
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	47.92	7.53	8.21	2.97	2.28	2.28	2.97
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	50.32	12.08	14.45	2.74	2.74	3.24	3.99
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	53.99	13.77	10.71	3.28	3.72	2.84	5.03
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	53.19	14.77	7.39	2.07	1.48	4.73	4.43
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	65.65	17.17	8.58	3.34	2.54	6.68	3.02
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	54.07	13.63	6.03	2.23	2.68	1.79	3.13
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	69.36	17.74	5.04	3.23	4.23	4.44	3.23
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	60.39	17.64	6.45	2.21	1.53	4.24	3.90
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	71.47	14.72	14.36	4.61	5.14	3.81	4.79
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	129.03	19.04	9.16	4.79	2.60	4.58	7.49
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	98.03	15.54	8.37	3.93	1.88	3.07	6.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	70.93	15.71	7.41	2.77	1.22	3.54	2.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	63.06	11.40	10.32	3.41	2.75	3.33	3.91
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	59.62	14.70	9.80	4.49	3.88	1.23	4.49
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	64.78	11.97	6.19	3.09	1.65	3.51	4.13
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	78.75	15.22	7.38	2.77	1.50	6.11	3.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	55.20	11.84	6.00	3.50	1.33	2.67	2.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	57.53	11.90	5.29	1.98	1.10	4.19	2.65
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	63.96	14.88	6.64	4.80	1.11	4.30	3.69
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	63.22	13.29	4.86	3.73	2.59	4.38	3.89
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	66.07	17.96	3.21	4.49	0.32	2.89	4.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	62.54	12.41	4.74	4.07	1.23	3.70	2.18
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	50.77	9.02	4.59	4.11	0.16	3.01	1.90
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	67.20	13.68	6.39	2.43	0.91	3.04	2.13
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	52.90	12.96	5.75	2.93	0.84	3.97	3.45
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	50.50	9.22	3.51	4.83	1.32	2.63	1.98
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	59.76	13.75	3.65	0.84	0.56	4.77	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	58.33	13.43	5.56	4.07	1.94	2.69	2.31
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	39.58	11.50	4.01	2.14	2.67	2.41	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	45.75	14.08	4.74	3.52	1.53	4.59	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	39.51	11.27	6.61	2.46	1.30	3.24	1.81
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	39.58	9.49	3.52	3.52	1.08	3.25	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	44.98	9.40	5.35	3.13	1.11	3.32	1.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	57.90	13.16	2.85	3.73	1.54	3.73	2.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	74.38	16.86	8.93	6.94	2.98	0.99	3.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	53.95	11.87	7.12	2.77	1.71	2.37	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	51.85	11.70	5.25	1.21	1.41	3.23	2.62
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	200.79	27.20	19.32	9.40	3.81	1.27	11.18
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	88.78	17.52	12.34	9.36	8.96	6.37	18.51
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	59.32	14.95	4.93	4.78	5.55	3.54	10.01
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	76.10	23.73	10.43	6.75	8.80	4.30	5.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	42.87	12.83	4.38	2.19	7.51	1.88	4.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	43.51	13.85	3.96	2.54	6.22	2.26	3.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	76.56	21.22	6.00	3.23	8.30	8.30	5.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	42.07	17.32	0.00	4.95	2.47	7.42	7.42
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	55.70	21.27	7.35	3.09	6.19	7.74	6.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	41.72	8.02	3.21	3.21	1.60	8.02	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	53.90	17.39	5.22	1.74	5.22	5.22	6.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	48.82	15.95	4.56	7.16	4.56	8.14	4.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	58.06	21.83	4.53	2.06	5.77	9.06	7.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	56.65	6.66	3.33	3.33	0.00	23.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	46.70	17.06	3.92	2.80	4.47	9.23	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	48.37	16.34	4.25	2.29	2.29	6.86	5.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	67.11	16.78	3.36	3.36	5.03	12.58	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	59.16	15.59	6.68	1.59	2.54	11.13	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	44.84	16.30	6.11	1.36	5.09	6.45	4.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	39.67	8.35	2.09	0.00	6.26	4.18	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	77.31	25.77	6.87	1.72	4.01	9.16	5.73
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	45.88	16.58	5.03	2.07	2.96	10.06	3.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	52.52	11.86	10.16	3.39	5.08	11.86	6.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	62.55	17.81	12.84	4.14	1.66	5.80	3.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	60.29	14.73	5.29	3.22	4.83	7.13	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	15.81	0.00	0.00	0.00	15.81	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	50.74	17.30	6.15	3.08	1.54	7.30	3.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	48.57	14.34	7.17	1.30	1.63	3.91	3.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	44.14	13.38	4.68	2.68	1.34	4.01	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	72.82	15.03	7.71	2.70	1.54	10.40	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	77.03	13.01	10.27	7.53	5.14	11.30	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	77.03	14.91	12.42	2.48	2.48	2.48	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	85.40	16.04	7.55	3.30	1.42	9.44	4.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	76.64	17.50	6.03	3.02	1.81	7.85	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	72.23	11.70	10.68	3.05	2.54	4.58	6.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	81.36	19.94	6.38	1.99	1.99	8.77	4.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	74.00	13.81	4.93	1.97	0.99	5.92	5.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	67.29	18.89	9.44	3.54	2.36	4.72	5.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	82.27	15.75	8.17	5.25	0.58	8.75	2.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	74.17	14.92	10.09	1.76	0.00	7.02	3.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	72.05	14.41	12.72	1.70	1.70	14.41	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	64.47	14.33	6.57	1.79	0.60	11.34	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	61.63	14.07	3.88	2.91	1.94	7.28	2.43
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	31.96	6.85	4.57	5.71	1.14	1.14	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	36.18	12.06	5.41	1.66	2.91	1.66	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	51.72	11.24	10.12	4.50	5.62	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	27.59	6.66	6.66	0.95	0.95	1.90	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	24.23	3.76	1.25	1.25	1.67	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	40.50	27.04	6.61	2.44	3.37	3.83	2.67
Hep-2 cells mock treated, biol_rep2	11899-125E9	37.81	24.98	6.58	2.87	3.88	4.05	2.19
Hep-2 cells mock treated, biol_rep3	11900-125F1	35.49	26.39	6.14	0.46	5.23	2.50	1.59
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	38.37	21.64	6.45	1.86	3.17	5.57	1.97
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	36.11	27.51	9.46	3.01	3.87	3.65	2.79
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	32.51	21.96	5.38	1.72	5.60	3.88	2.80
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	35.74	20.42	6.60	2.37	3.36	4.48	2.24
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	27.28	19.73	8.58	2.06	3.09	4.12	1.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	29.15	23.71	5.13	2.24	1.92	2.88	1.92
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	67.71	23.50	2.80	8.95	1.68	2.24	3.92
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	58.86	23.80	7.36	3.46	2.60	1.73	2.16
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	23.79	13.22	5.29	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	82.18	15.17	10.93	4.23	1.06	1.41	3.88
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	58.85	16.71	7.27	3.63	0.00	2.18	2.91
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	41.61	11.19	5.07	4.37	2.80	2.27	1.92
Hepatocyte, donor1	11523-119I2	30.27	18.16	3.63	1.21	1.21	3.63	1.21
Hepatocyte, donor2	11603-120I1	15.08	23.70	7.54	0.00	3.23	1.08	0.00
Hepatocyte, donor3	11684-122I1	24.54	18.41	3.68	1.84	1.23	1.84	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	89.42	30.68	3.26	1.96	5.22	1.96	5.87
Intestinal epithelial cells (polarized), donor1	11246-116E4	114.13	24.99	14.68	6.29	3.15	3.15	6.47
Iris Pigment Epithelial Cells, donor1	11530-119I9	34.44	7.68	6.86	3.16	1.65	1.37	1.92
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	19.10	15.92	0.00	0.00	12.74	3.18	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	12.46	20.77	4.15	1.38	1.38	0.00	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	27.53	10.01	2.50	0.00	2.50	2.50	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	59.34	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	20.50	0.00	2.56	5.13	0.00	5.13
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	9.14	0.00	0.00	9.14	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	17.87	27.61	1.62	3.25	3.25	0.00	4.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	15.01	28.34	1.67	5.00	3.33	0.00	6.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	18.15	3.63	0.00	3.63	3.63	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	27.79	26.47	7.94	0.00	3.97	0.00	2.65
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	19.96	32.15	1.11	1.11	5.54	1.11	4.43
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	20.95	0.00	0.00	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	22.05	25.82	0.63	1.26	2.52	2.52	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	18.56	10.83	3.09	0.00	6.19	1.55	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	0.00	14.63	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	19.38	18.09	3.88	0.65	5.81	0.65	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	16.10	22.54	6.44	1.61	3.22	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	35.84	0.00	0.00	0.00	0.00	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	20.37	25.26	4.07	1.63	5.70	2.44	3.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	14.69	23.09	5.04	0.00	5.88	0.00	1.68
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	28.74	0.00	0.00	14.37	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	16.88	26.52	1.61	1.61	6.43	0.80	5.63
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	19.39	30.47	4.62	1.85	1.85	0.92	3.69
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	30.16	0.00	0.00	0.00	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	21.24	16.52	2.83	0.47	3.78	1.42	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	21.77	14.51	3.63	0.00	4.53	1.81	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	17.22	32.28	2.15	2.15	3.23	3.23	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	24.14	25.41	5.08	1.27	3.81	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	20.41	28.06	6.38	0.00	2.55	0.64	4.46
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	16.40	23.69	0.00	0.00	1.82	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	25.71	26.42	5.71	0.00	3.57	0.71	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	6.64	19.91	0.00	0.00	0.00	3.32	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	23.46	21.91	3.70	0.31	7.10	2.47	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	14.05	29.85	7.02	0.00	1.76	0.00	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	9.43	28.29	3.14	0.00	6.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	19.47	24.34	6.95	0.70	4.87	0.70	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	39.84	6.64	4.43	0.00	4.43	6.64	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	22.69	32.42	0.00	0.00	0.00	3.24	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	29.65	30.52	2.62	0.00	4.36	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	29.25	6.75	2.25	0.00	4.50	2.25	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	20.91	20.91	0.00	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	27.74	22.40	2.13	1.07	3.20	2.13	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	20.78	9.70	2.77	1.39	2.77	2.77	4.16
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	22.80	2.85	0.00	11.40	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.93	22.09	1.84	0.00	0.92	0.00	2.76
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	18.15	0.00	0.00	3.03	0.00	9.08
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	0.00	0.00	0.00	0.00	0.00	12.42
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	20.09	24.32	1.06	2.11	0.00	4.23	7.40
Keratinocyte - epidermal, donor1	11272-116H3	29.70	12.73	7.59	1.96	2.77	1.39	0.98
Keratinocyte - epidermal, donor2	11349-117G8	22.84	10.54	2.93	0.00	4.10	2.34	1.17
Keratinocyte - epidermal, donor3	11421-118F8	30.38	20.35	4.83	1.42	2.93	3.60	1.89
Keratinocyte - oral, donor1	11251-116E9	62.32	17.03	10.90	4.77	4.88	1.25	6.24
Keratocytes, donor1	11527-119I6	72.55	17.54	29.91	3.09	4.13	1.03	3.78
Keratocytes, donor2	11607-120I5	55.07	16.41	9.37	3.52	5.86	1.17	1.17
Keratocytes, donor3	11688-122I5	46.63	9.68	3.75	3.75	0.79	2.17	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	118.69	32.97	4.40	4.40	6.59	0.00	4.40
Lens Epithelial Cells, donor1	11529-119I8	32.36	10.79	14.02	4.31	4.31	4.31	0.00
Lens Epithelial Cells, donor2	11609-120I7	54.44	6.23	6.23	3.92	1.04	2.42	4.50
Lens Epithelial Cells, donor3	11690-122I7	42.58	7.06	5.55	4.24	2.02	0.81	1.11
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	44.94	13.87	4.62	5.10	1.90	1.78	2.37
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	35.72	8.65	1.67	2.79	0.84	2.79	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	46.91	11.65	3.31	5.51	1.10	1.57	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	29.57	10.22	4.30	1.08	2.15	2.69	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	46.96	13.24	3.47	1.89	1.89	3.78	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	38.38	11.75	2.70	2.91	1.19	2.48	1.29
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	33.65	9.03	4.92	2.05	2.46	2.46	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	33.88	10.11	3.79	2.28	1.77	1.52	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	36.88	11.12	3.66	3.52	0.84	2.11	2.11
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	22.15	7.91	1.58	2.77	1.19	1.19	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	38.97	10.86	2.33	2.52	1.16	1.94	1.36
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	34.07	11.11	3.89	3.15	0.56	1.11	1.30
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	34.84	10.80	3.83	1.74	0.70	2.09	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	34.59	10.50	0.95	2.62	1.19	2.39	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	38.32	11.54	3.16	3.43	1.92	2.33	0.96
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	36.65	10.16	2.77	2.16	0.62	2.77	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	30.24	8.11	1.87	2.81	0.62	3.12	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	46.85	11.16	3.48	3.11	0.73	2.56	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	34.56	13.82	2.30	3.62	0.99	3.95	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	36.90	13.76	2.34	1.46	1.17	2.64	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	45.80	12.45	4.48	3.24	1.49	1.74	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	27.64	9.70	1.94	2.42	2.91	2.42	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	32.58	13.20	1.62	1.62	1.89	2.15	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	42.84	13.47	4.54	4.39	0.76	3.03	1.06
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	27.99	10.37	4.67	4.15	3.11	1.56	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	34.55	12.14	1.88	2.30	1.88	3.14	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	40.90	12.18	2.56	2.11	1.20	2.11	1.05
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	27.52	8.25	4.13	2.06	0.69	2.06	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	26.72	7.15	2.26	3.39	1.88	2.63	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	42.20	12.62	3.18	3.92	1.48	2.44	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	27.62	9.21	4.85	2.91	1.45	1.94	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	26.13	6.28	2.32	2.98	0.99	2.32	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	44.72	10.53	2.97	1.98	1.24	2.97	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	30.73	11.85	4.07	3.33	0.00	3.70	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	23.23	4.94	2.47	1.48	1.48	1.48	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	33.55	14.02	3.30	3.02	1.10	2.34	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	30.88	10.29	3.22	3.22	0.64	2.89	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	31.35	9.43	2.43	3.96	0.91	2.43	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	40.73	11.06	3.78	3.22	0.70	4.06	0.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	30.93	10.31	2.49	0.71	0.36	1.07	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	24.24	13.09	1.94	0.97	0.97	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	36.26	11.83	3.11	2.33	1.40	1.56	0.93
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	29.36	7.88	2.15	1.43	1.79	0.72	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	35.93	6.53	3.92	2.94	1.63	0.33	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	32.25	10.12	3.06	1.88	1.88	1.88	1.41
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	38.61	15.10	6.31	4.33	2.10	1.73	3.09
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	28.94	7.43	3.07	3.33	1.28	1.54	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	35.21	11.04	5.07	4.77	1.79	1.19	1.49
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	79.31	13.60	4.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	99.73	13.04	7.67	5.37	3.07	4.60	3.84
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	80.90	12.62	5.20	1.48	1.48	3.71	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	95.20	19.46	2.96	2.96	3.39	5.08	2.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	67.52	13.36	2.11	6.33	3.52	8.44	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	63.51	9.34	1.87	1.87	0.00	7.47	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	79.35	14.94	4.12	1.55	1.55	7.73	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	79.69	16.65	4.76	2.38	1.19	2.38	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	83.01	11.76	3.62	4.75	2.04	0.90	3.85
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	89.87	13.09	4.94	3.49	1.45	9.31	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	83.28	12.60	9.90	4.50	1.35	6.30	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	114.89	15.85	5.69	5.55	1.49	2.71	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	94.49	20.54	3.59	3.08	1.54	7.19	3.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	92.10	15.88	4.94	5.65	1.06	5.29	3.53
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	61.30	10.66	0.67	3.33	2.00	6.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	91.18	21.39	4.08	1.53	2.55	8.66	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	105.12	16.54	8.00	4.54	1.07	7.20	3.20
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	99.39	16.63	4.35	3.21	2.65	6.05	0.76
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	69.95	15.95	6.75	2.45	0.61	7.98	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	106.00	27.72	8.15	4.89	2.45	8.15	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	116.82	16.66	8.12	6.66	2.08	10.00	2.92
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	94.73	17.38	5.32	2.52	0.84	12.61	3.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	79.34	20.61	5.15	4.12	6.18	7.21	5.15
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	115.83	23.51	5.23	5.23	1.16	13.35	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	90.58	16.74	5.38	2.99	1.49	5.98	3.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	98.48	9.41	5.53	3.87	0.00	11.07	3.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	112.41	23.68	5.30	4.95	1.77	5.30	3.18
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	87.03	19.55	6.27	1.84	1.84	6.27	4.79
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	78.29	13.82	4.61	4.61	2.30	3.45	3.45
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	87.50	21.11	4.22	3.45	0.77	3.45	2.69
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	93.41	23.21	7.93	3.40	0.57	7.36	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	85.33	19.69	6.56	3.28	2.46	6.56	4.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	109.36	23.05	6.78	2.71	1.36	7.23	2.71
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	81.87	16.52	3.59	2.15	2.87	5.03	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	110.54	14.94	5.23	1.49	1.49	10.46	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	115.19	27.50	7.43	6.32	1.11	8.92	2.23
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	87.44	13.35	5.17	0.86	2.58	6.46	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	92.48	13.70	6.85	5.14	0.00	8.56	5.14
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	110.95	16.99	6.66	4.66	1.67	8.66	4.66
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	83.26	24.13	7.24	1.21	1.21	6.64	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	86.74	9.24	11.38	3.55	1.42	4.27	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	105.52	17.19	7.22	4.47	1.72	8.59	5.16
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	84.27	17.71	4.83	5.37	1.07	8.59	2.68
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	85.52	14.81	8.08	4.71	0.00	6.73	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	104.83	18.52	5.19	5.19	0.74	9.63	2.96
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	76.75	12.79	6.98	2.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	81.45	14.81	4.23	3.17	1.06	2.12	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	99.24	20.81	4.00	5.20	2.40	6.40	2.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	69.78	15.26	4.36	0.73	1.45	4.36	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	71.29	13.03	3.83	1.53	0.00	4.60	3.83
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	97.67	17.76	3.95	1.97	3.45	8.88	3.95
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	66.81	9.41	4.70	1.88	0.00	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	89.50	15.08	7.04	3.02	1.01	3.02	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	90.58	21.18	4.06	2.25	2.70	5.86	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	79.17	10.33	10.33	1.72	0.00	12.05	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	92.19	15.59	3.12	3.12	0.89	8.02	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	105.58	17.60	4.69	3.52	1.17	10.17	2.35
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	63.33	16.49	3.30	1.32	0.66	3.96	1.98
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	100.15	11.42	8.82	4.67	2.08	5.19	3.11
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	101.95	26.69	5.25	4.81	1.31	5.69	3.06
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	76.60	16.21	6.15	1.12	1.68	3.35	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	88.77	18.11	7.51	3.97	2.21	3.09	4.42
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	100.29	20.06	5.40	4.24	1.93	6.56	5.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	75.45	16.71	8.10	1.52	1.52	6.58	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	86.99	17.30	7.69	4.81	1.92	3.84	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	97.80	19.48	7.55	4.77	1.59	5.57	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	79.60	15.19	3.04	5.47	0.00	4.25	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	91.30	19.37	2.77	2.08	2.08	4.15	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	91.58	20.52	5.70	4.94	1.52	7.98	4.94
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	67.65	16.01	9.30	1.55	1.55	4.65	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	122.74	20.56	9.07	4.84	3.63	8.47	4.84
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	100.14	21.55	6.97	5.39	0.63	5.70	1.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	74.63	12.79	5.86	3.20	1.60	3.20	3.20
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	97.69	17.81	5.75	2.87	3.45	5.75	4.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	95.13	17.48	12.34	4.63	3.60	8.23	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	77.81	12.03	11.32	2.12	0.71	5.66	4.95
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	113.50	17.02	13.05	5.67	2.27	5.67	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	100.68	23.71	8.74	1.66	2.91	6.66	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	72.04	17.23	7.05	0.00	3.92	7.83	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	88.10	12.11	5.85	2.92	2.09	7.93	2.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	82.71	16.26	5.11	4.65	0.93	5.11	2.79
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	87.65	14.05	6.69	2.68	0.67	5.35	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	139.54	19.25	10.69	4.81	3.21	3.74	4.28
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	93.35	15.36	11.31	3.23	2.83	6.87	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	53.23	12.85	4.59	2.75	1.84	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	112.03	22.23	6.22	4.45	1.78	5.33	3.56
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	100.87	15.96	6.84	2.85	1.71	2.85	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	76.69	11.50	3.07	3.07	3.07	4.60	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	114.91	16.42	8.21	3.83	1.09	6.57	1.64
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	86.42	20.49	8.91	2.23	2.67	1.78	2.67
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	102.42	18.72	10.40	2.86	1.30	2.86	1.82
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	106.10	15.25	8.62	5.97	1.99	3.98	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	101.85	14.55	2.08	6.24	0.00	8.31	4.16
Macrophage - monocyte derived, donor1	11232-116C8	47.86	9.34	0.91	1.37	0.23	0.46	0.68
Macrophage - monocyte derived, donor2	11313-117C8	24.96	8.26	1.65	0.37	0.18	0.92	0.18
Macrophage - monocyte derived, donor3	11389-118C3	32.38	18.88	1.18	0.92	0.13	0.39	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	9.03	6.37	4.25	1.59	2.66	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	20.44	12.20	9.19	1.58	3.17	0.48	0.48
Mallassez-derived cells, donor3	11930-125I4	23.63	13.90	9.31	1.95	3.47	1.11	0.42
Mammary Epithelial Cell, donor1	11273-116H4	38.46	9.37	6.08	2.09	4.68	3.09	2.29
Mammary Epithelial Cell, donor2	11350-117G9	30.11	11.29	8.98	2.03	5.79	2.90	2.61
Mammary Epithelial Cell, donor3	11422-118F9	36.42	23.20	8.23	2.49	2.74	0.25	3.74
Mast cell - stimulated, donor1	11487-119E2	76.61	12.20	7.46	10.85	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	81.54	10.92	0.65	5.08	0.65	2.92	1.08
Mast cell, donor2	11565-120D8	142.05	18.72	2.38	7.13	2.38	2.08	6.54
Mast cell, donor3	11566-120D9	163.44	20.94	0.68	7.88	0.23	3.15	4.73
Mast cell, donor4	11567-120E1	146.62	19.50	0.35	5.32	0.53	1.06	3.37
Mast cell, expanded and stimulated, donor5	11940-126A5	66.65	23.62	1.66	2.33	0.22	1.44	1.00
Mast cell, expanded and stimulated, donor8	11942-126A7	54.87	18.68	1.17	2.33	1.75	3.50	0.58
Mast cell, expanded, donor5	11939-126A4	69.75	16.18	0.80	3.21	0.00	1.26	0.46
Mast cell, expanded, donor8	11941-126A6	101.93	25.77	1.00	4.52	1.00	2.68	1.00
Melanocyte - dark, donor1	11502-119F8	45.17	11.04	2.49	5.27	0.90	1.69	1.29
Melanocyte - dark, donor2	11582-120F7	38.76	15.57	6.92	2.08	0.69	3.11	2.08
Melanocyte - dark, donor3	11663-122F7	58.82	10.36	4.35	5.72	2.61	2.46	1.45
Melanocyte - light, donor1	11274-116H5	41.37	11.05	4.23	4.70	1.18	1.41	0.71
Melanocyte - light, donor2	11351-117H1	60.74	16.38	3.41	9.55	2.05	0.68	2.05
Melanocyte - light, donor3	11423-118G1	49.43	8.67	2.60	4.34	3.47	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	37.80	12.50	6.77	3.33	2.39	3.12	1.77
Melanocyte, donor2 (MC+2)	12739-135I3	31.74	11.03	5.65	2.96	1.61	0.81	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	44.20	15.54	6.16	5.36	1.61	2.68	0.54
Meningeal Cells, donor1	11493-119E8	120.46	38.58	21.46	10.05	13.89	1.74	9.18
Meningeal Cells, donor2	11573-120E7	70.86	32.13	8.80	5.72	5.28	0.44	8.80
Meningeal Cells, donor3	11654-122E7	60.39	24.37	11.00	3.99	8.39	3.67	1.63
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	61.31	13.40	9.70	3.14	3.14	0.86	1.43
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	25.86	5.03	8.55	4.33	3.12	0.60	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	46.00	6.57	7.88	2.63	1.31	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	52.33	15.70	2.62	2.62	9.16	1.31	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	28.70	12.20	5.02	2.87	2.87	3.59	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	24.99	7.84	6.35	2.54	2.12	2.12	1.27
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	40.71	10.56	9.05	1.01	1.01	2.51	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	72.52	12.09	12.31	9.45	4.61	3.08	2.64
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	80.36	21.19	6.58	8.04	5.11	7.31	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	70.38	18.82	9.62	4.91	4.30	3.27	1.23
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	42.24	4.71	6.37	2.49	1.11	1.52	2.35
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	50.93	5.58	11.52	4.09	1.86	1.12	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	43.68	8.42	10.13	2.63	1.05	2.11	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	28.19	3.56	7.72	2.37	0.89	3.26	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	30.36	9.34	7.01	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	85.17	14.73	10.25	5.76	3.20	1.28	5.12
Mesenchymal stem cells - adipose, donor0	11217-116B2	36.15	9.92	11.34	4.61	3.54	0.71	2.84
Mesenchymal stem cells - hepatic, donor0	11218-116B3	37.21	6.57	9.69	3.75	0.63	1.25	1.88
Mesenchymal stem cells - umbilical, donor0	11214-116A8	37.01	10.89	4.35	0.00	2.18	1.45	1.45
Mesothelial Cells, donor1	11247-116E5	28.90	9.55	8.49	4.51	0.80	2.12	0.80
Mesothelial Cells, donor2	12156-128G5	16.01	6.01	6.51	3.50	1.50	1.00	0.00
Mesothelial Cells, donor3	11402-118D7	25.00	9.90	7.44	2.38	1.30	2.24	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	56.71	48.61	2.70	4.05	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	41.37	24.87	1.72	0.99	0.25	1.72	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	26.21	17.67	2.94	0.88	0.29	0.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	48.40	27.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	36.88	13.64	0.62	1.55	0.93	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	23.23	9.54	0.83	0.83	0.00	1.45	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	50.95	25.48	2.32	2.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	33.28	15.27	0.50	2.00	0.75	1.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	29.79	13.96	0.93	0.93	0.00	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	38.93	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	33.12	16.26	1.22	0.81	0.20	0.81	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	22.97	13.46	2.38	1.58	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	25.65	0.00	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	23.01	12.39	0.88	0.88	0.00	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	19.38	6.84	1.90	0.76	0.38	1.14	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	35.53	22.37	0.00	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	23.77	12.52	0.42	0.85	0.21	1.06	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	24.86	21.18	0.92	0.92	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	24.14	12.82	0.30	0.30	0.60	1.49	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	43.59	6.71	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	22.83	12.29	1.00	0.50	0.25	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	16.16	12.60	0.95	0.95	0.00	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	34.28	16.59	0.55	0.55	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	15.89	11.05	0.23	0.23	0.46	1.15	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	22.51	11.15	1.68	1.47	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	17.33	7.34	0.82	1.43	0.00	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	22.74	7.94	0.64	0.64	0.00	1.07	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	19.56	14.23	1.11	0.22	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	51.59	20.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	15.99	7.01	1.10	1.10	0.44	0.88	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	22.31	7.10	0.51	0.51	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	26.51	11.60	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	19.30	8.70	1.09	0.54	0.27	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	19.12	9.41	0.59	0.29	1.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	16.35	14.17	1.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	10.57	5.29	1.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	20.01	11.61	0.80	0.80	0.00	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	20.57	20.57	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	15.02	5.51	1.50	0.50	0.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	16.31	24.46	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	10.95	7.88	4.38	0.00	0.44	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	20.97	9.93	2.21	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	24.33	8.33	1.28	1.28	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.88	9.17	3.22	0.50	0.00	1.24	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	25.75	14.61	2.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	33.15	19.89	2.21	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	15.04	10.94	8.89	1.37	0.34	1.03	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	27.57	9.63	3.06	3.06	0.88	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	26.63	12.78	3.55	0.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	21.32	9.54	5.33	0.84	0.00	1.96	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	24.11	9.14	5.82	1.66	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	29.14	15.15	1.75	1.17	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	19.61	11.46	3.62	0.30	0.30	0.90	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	22.54	9.18	7.93	2.09	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	28.88	14.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	23.09	11.08	1.85	0.00	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	26.75	11.95	6.83	0.57	0.57	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	27.36	13.27	5.80	0.97	0.69	0.41	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	23.58	9.85	4.41	1.04	1.04	1.04	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	26.17	13.73	4.29	0.86	0.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	28.58	9.53	3.81	1.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	23.22	9.34	4.80	0.53	0.27	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	26.04	12.57	6.88	0.30	1.20	1.80	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	24.15	10.03	2.68	0.85	0.14	0.99	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	20.07	11.78	3.50	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	28.75	11.50	6.86	1.99	0.22	1.77	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	35.64	12.51	1.52	0.76	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	18.75	11.93	4.55	0.57	0.57	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	21.14	12.04	6.64	0.98	0.49	1.72	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	28.67	12.38	3.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	26.17	14.70	4.12	0.59	0.59	0.88	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	19.03	12.69	6.92	1.15	0.58	1.15	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	32.97	17.31	6.59	1.65	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	27.10	14.59	5.66	0.30	0.00	0.00	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	3.77	7.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	19.60	3.56	1.78	0.00	0.00	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	34.50	22.67	1.97	1.31	0.66	3.29	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	21.04	8.42	2.10	2.10	1.05	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	27.28	11.07	0.20	1.78	0.00	0.59	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	29.80	15.83	0.93	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	37.18	12.77	0.75	1.50	0.38	1.88	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	21.84	15.45	0.00	0.53	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	22.73	14.14	0.68	0.90	0.11	0.45	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	25.79	11.79	0.74	2.21	0.00	2.95	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	34.44	17.95	1.47	0.37	0.37	1.47	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	23.33	12.44	1.56	0.00	0.00	12.44	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	28.33	12.29	0.00	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	46.37	7.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	31.31	14.14	0.00	1.01	0.00	4.04	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	27.41	10.12	0.00	1.26	0.00	1.26	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	23.15	8.17	1.36	0.00	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.99	1.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	2.43	0.00	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	21.15	4.53	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	17.13	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	6.52	9.79	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	4.75	4.75	9.50	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	27.14	9.26	5.60	4.31	3.88	1.72	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	45.47	9.93	3.66	4.18	2.09	2.61	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	22.03	6.67	3.34	4.67	0.67	4.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	24.62	5.84	3.34	4.59	0.83	1.25	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	48.11	13.50	8.94	3.42	1.90	9.32	1.14
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	146.82	60.64	12.77	7.98	1.60	1.60	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	17.00	6.12	0.00	2.04	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	33.08	22.05	22.05	1.84	3.68	3.68	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.83	4.60	1.26	0.84	1.26	3.35	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	29.05	4.88	4.42	4.42	1.39	6.51	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	28.37	11.62	0.81	0.81	0.27	1.89	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	52.77	15.56	3.36	1.89	0.84	1.68	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	22.27	22.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	31.27	5.46	0.50	1.49	0.99	1.49	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	25.98	7.04	0.81	2.17	0.81	8.93	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	14.96	4.76	1.59	1.13	1.13	6.12	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	24.66	5.06	1.47	1.47	0.16	3.27	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	43.19	14.58	5.47	3.10	1.09	1.46	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	30.23	7.96	2.12	2.65	0.53	3.71	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	24.61	6.00	0.60	1.20	1.80	3.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	31.83	10.83	7.55	2.95	0.66	15.42	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	17.40	4.23	1.46	2.11	0.16	2.93	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	60.32	18.17	3.17	3.70	0.88	1.94	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	18.99	6.33	2.81	0.00	2.11	2.11	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	16.09	8.27	1.84	1.38	0.00	6.44	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	24.10	6.11	1.29	2.57	0.32	1.61	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	25.18	8.62	9.31	3.79	0.00	16.21	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	78.38	27.81	22.76	0.00	0.00	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	50.13	14.04	2.90	3.12	0.22	1.11	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	19.90	11.85	0.85	1.27	0.42	6.35	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	24.21	6.88	2.85	1.19	0.24	4.75	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	18.46	6.87	1.72	2.58	0.00	4.72	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	81.25	27.08	81.25	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	30.99	8.66	1.00	1.67	0.00	5.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	42.38	14.88	0.90	1.80	1.80	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	11.90	5.56	0.79	0.40	0.40	4.76	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	17.64	8.36	0.93	1.86	0.00	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	23.46	6.43	3.41	1.14	0.76	2.27	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	17.92	7.17	1.30	1.30	0.98	4.56	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	31.38	6.10	0.00	2.18	0.00	1.31	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	46.59	21.26	4.07	3.62	1.36	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	16.76	7.06	0.00	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	27.26	4.65	1.33	0.00	0.00	3.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	24.31	6.94	0.99	0.50	0.00	2.98	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	26.41	8.80	2.68	3.45	0.38	3.83	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	35.99	10.89	2.72	1.21	0.30	3.33	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	33.82	19.23	1.99	1.77	0.66	1.55	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	16.94	8.81	2.03	3.39	0.00	5.42	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	45.99	15.33	10.22	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	20.12	7.32	1.83	3.05	0.00	3.66	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	20.77	6.61	0.63	1.26	0.31	2.83	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	27.24	13.62	0.30	1.82	0.30	3.03	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	20.57	5.54	0.79	0.79	0.00	3.16	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	35.14	18.14	7.94	3.40	3.40	10.20	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	50.58	30.35	25.29	0.00	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	21.37	5.22	7.33	2.73	2.11	0.99	0.50
Myoblast, donor2	11322-117D8	45.84	14.77	6.33	3.26	1.15	4.22	0.96
Myoblast, donor3	11398-118D3	44.90	8.91	8.07	5.21	1.35	2.69	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	77.49	38.38	2.48	3.50	1.17	3.21	3.65
Natural Killer Cells, donor1	11230-116C6	157.76	20.91	1.54	11.38	1.54	3.08	0.92
Natural Killer Cells, donor2	11311-117C6	140.83	39.50	1.81	8.75	2.71	11.46	1.21
Natural Killer Cells, donor3	11387-118C1	131.78	29.45	1.66	11.96	2.21	4.05	1.10
Neural stem cells, donor1	11275-116H6	119.04	34.84	12.70	4.36	3.63	5.81	2.90
Neural stem cells, donor2	11352-117H2	182.94	36.59	7.70	7.70	3.85	1.93	1.93
Neurons, donor1	11494-119E9	89.89	21.62	2.28	3.41	2.28	3.41	1.14
Neurons, donor2	11574-120E8	85.64	16.95	2.42	2.20	1.98	1.32	1.54
Neurons, donor3	11655-122E8	71.53	20.55	2.47	0.82	0.00	13.98	0.82
Neutrophils, donor1	11233-116C9	123.42	61.25	0.00	0.93	0.93	18.56	0.00
Neutrophils, donor2	11314-117C9	168.13	75.37	2.90	0.00	0.00	26.09	0.00
Neutrophils, donor3	11390-118C4	142.33	50.09	0.00	2.44	0.00	1.83	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	91.07	18.52	11.64	4.99	0.71	2.26	2.14
Nucleus Pulposus Cell, donor2	11409-118E5	45.58	6.51	2.28	2.60	0.65	4.56	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	46.93	9.02	4.81	1.80	1.00	2.41	0.80
Olfactory epithelial cells, donor1	11933-125I7	34.41	8.67	3.85	2.20	1.24	3.85	0.28
Olfactory epithelial cells, donor2	11934-125I8	39.52	8.11	4.49	3.62	2.46	7.67	0.43
Olfactory epithelial cells, donor3	11935-125I9	27.24	7.26	3.41	1.93	1.82	4.54	0.11
Olfactory epithelial cells, donor4	11936-126A1	50.74	12.17	4.87	3.80	2.53	2.05	0.68
Oligodendrocyte - precursors, donor1	11496-119F2	44.53	8.43	20.46	5.42	4.21	3.61	3.01
Osteoblast - differentiated, donor1	11276-116H7	72.10	12.55	8.72	4.25	1.70	0.21	1.49
Osteoblast - differentiated, donor2	11353-117H3	28.58	10.29	3.43	3.43	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	24.21	6.21	1.24	1.24	0.00	1.24	1.24
Osteoblast, donor1	11277-116H8	100.26	16.22	8.21	7.62	3.71	0.39	3.13
Osteoblast, donor2	11354-117H4	75.85	16.15	10.53	4.92	7.73	5.62	1.40
Osteoblast, donor3	11426-118G4	71.80	21.68	10.66	7.46	5.51	0.89	0.53
Pancreatic stromal cells, donor1	11249-116E7	45.32	10.19	8.84	5.05	2.27	2.61	1.10
Pericytes, donor1	11491-119E6	87.34	15.47	5.79	1.78	1.00	1.67	4.90
Pericytes, donor2	11571-120E5	74.93	21.96	3.85	2.94	1.81	3.17	3.85
Pericytes, donor3	11652-122E5	43.33	16.07	7.53	3.66	2.64	3.26	1.02
Perineurial Cells, donor1	11499-119F5	44.76	8.70	7.12	3.50	3.28	1.47	2.60
Perineurial Cells, donor2	11579-120F4	55.11	12.88	10.86	4.32	1.38	1.84	1.56
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	159.37	31.87	3.19	7.65	1.59	2.87	2.55
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	85.70	36.48	0.98	3.43	1.71	5.88	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	91.89	45.68	1.29	6.08	1.29	3.11	0.65
Placental Epithelial Cells, donor1	11278-116H9	25.83	11.96	9.09	1.20	2.15	0.72	3.11
Placental Epithelial Cells, donor2	11355-117H5	27.72	9.98	6.65	2.22	0.00	0.00	4.44
Placental Epithelial Cells, donor3	11427-118G5	50.06	17.47	5.10	2.55	1.96	1.96	1.96
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	20.89	8.23	1.27	1.58	0.95	8.23	0.00
Preadipocyte - breast, donor1	11467-119B9	29.83	6.57	3.94	1.31	1.69	1.13	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	18.40	7.83	4.83	1.04	0.13	0.39	0.78
Preadipocyte - breast, donor2	11328-117E5	35.80	19.36	2.48	2.03	0.68	2.03	0.45
Preadipocyte - omental, donor1	11468-119C1	31.12	8.52	4.05	1.92	1.81	2.34	0.32
Preadipocyte - omental, donor2	11329-117E6	36.66	6.98	7.86	1.75	0.87	1.31	0.44
Preadipocyte - omental, donor3	11403-118D8	30.66	9.02	4.01	2.01	2.72	3.87	0.86
Preadipocyte - perirenal, donor1	11469-119C2	20.67	2.95	5.91	1.97	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	39.93	11.67	17.51	2.76	7.99	0.61	1.54
Preadipocyte - subcutaneous, donor2	11356-117H6	61.45	26.21	14.87	2.30	6.55	9.92	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	38.65	14.30	8.51	2.55	5.28	2.89	0.85
Preadipocyte - visceral, donor1	11280-116I2	51.04	15.93	13.69	2.89	4.01	4.75	1.40
Preadipocyte - visceral, donor2	11357-117H7	47.86	16.57	8.28	2.30	1.84	5.98	0.00
Preadipocyte - visceral, donor3	11429-118G7	51.62	19.02	8.46	3.45	4.08	3.76	1.57
Prostate Epithelial Cells (polarized), donor1	11253-116F2	94.28	16.74	18.25	5.88	4.83	4.68	5.88
Prostate Epithelial Cells, donor2	11331-117E8	22.07	9.48	5.69	1.90	1.49	2.57	0.00
Prostate Epithelial Cells, donor3	11404-118D9	18.55	12.61	2.39	0.92	2.88	2.76	0.92
Prostate Stromal Cells, donor1	11254-116F3	44.54	14.01	11.73	3.53	5.58	1.03	0.46
Prostate Stromal Cells, donor2	11332-117E9	41.78	13.45	7.35	2.69	6.10	5.56	0.54
Prostate Stromal Cells, donor3	11405-118E1	33.79	8.03	3.23	2.19	1.36	4.48	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	66.06	11.68	9.12	7.30	4.01	1.82	7.66
Renal Cortical Epithelial Cells, donor2	11596-120H3	36.18	9.43	10.60	2.70	2.36	1.52	2.36
Renal Epithelial Cells, donor1	11517-119H5	71.52	18.26	10.14	5.58	7.10	2.03	5.07
Renal Epithelial Cells, donor2	11597-120H4	79.67	22.05	9.96	2.85	3.56	1.42	4.27
Renal Epithelial Cells, donor3	11678-122H4	47.96	9.21	11.86	2.96	2.54	0.85	1.69
Renal Glomerular Endothelial Cells, donor1	11514-119H2	69.45	23.15	4.09	8.85	2.72	1.36	6.13
Renal Glomerular Endothelial Cells, donor2	11594-120H1	54.31	20.62	6.20	5.66	3.91	2.96	2.83
Renal Glomerular Endothelial Cells, donor3	11675-122H1	81.70	20.20	12.65	6.66	2.89	3.77	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	41.26	9.32	0.00	1.33	1.33	1.33	0.67
Renal Mesangial Cells, donor1	11518-119H6	72.41	13.65	11.66	7.04	5.50	1.76	3.08
Renal Mesangial Cells, donor2	11598-120H5	91.54	16.30	12.54	3.76	1.88	1.25	1.25
Renal Mesangial Cells, donor3	11679-122H5	59.37	13.32	9.99	4.44	1.94	1.66	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	67.11	19.33	15.84	5.91	5.10	2.42	2.42
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	47.23	24.46	6.75	2.11	2.11	0.84	2.11
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	83.89	24.11	13.88	6.17	4.24	1.74	2.89
Retinal Pigment Epithelial Cells, donor0	11215-116A9	44.08	11.41	3.89	2.59	2.85	1.81	2.33
Retinal Pigment Epithelial Cells, donor1	11528-119I7	63.67	12.22	9.66	2.84	3.41	1.71	3.13
Retinal Pigment Epithelial Cells, donor2	11608-120I6	54.54	14.41	6.17	5.15	4.12	1.03	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	26.60	5.27	5.27	1.00	2.01	2.01	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	61.34	18.58	3.07	1.74	1.34	1.07	1.34
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	134.01	32.16	19.65	9.83	2.68	7.15	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	140.89	40.73	45.68	5.50	6.05	22.57	8.81
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	270.31	57.43	23.78	9.86	3.48	6.96	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	174.10	39.66	30.04	12.87	5.85	5.33	6.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	152.33	41.71	20.46	9.14	4.77	8.84	3.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	147.01	32.12	23.31	12.38	5.02	5.47	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	187.43	42.42	36.10	9.92	4.34	7.19	6.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	137.99	42.66	21.44	6.88	4.08	9.91	4.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	152.55	52.93	21.03	9.01	5.32	12.94	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	157.17	38.47	26.01	8.49	3.42	6.16	5.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	143.41	45.38	23.30	12.25	3.33	8.77	3.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	151.06	32.43	18.10	12.90	3.94	1.97	3.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	149.05	35.86	21.38	10.19	4.59	8.18	3.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	133.61	39.92	19.10	9.01	3.86	6.44	3.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	146.70	40.05	21.68	9.74	1.99	11.28	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	174.74	36.13	19.31	8.03	3.82	4.78	3.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	139.56	40.99	19.66	12.58	4.10	5.40	3.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	163.86	31.57	26.87	9.96	5.64	8.83	4.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	187.78	38.62	16.59	10.75	3.72	5.18	4.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	164.90	42.54	21.12	9.64	5.16	6.04	3.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	143.60	35.52	18.14	9.36	4.39	16.61	3.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	164.57	36.52	19.22	9.72	5.02	6.41	3.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	136.51	42.89	20.46	10.09	5.61	20.46	3.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	156.88	43.41	19.65	10.25	4.27	5.47	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	159.90	38.29	14.04	11.12	4.92	4.92	3.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	143.23	36.42	19.74	10.67	4.05	6.87	3.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	160.51	46.47	20.01	10.61	4.57	7.12	4.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	149.78	28.78	19.11	6.84	6.13	8.73	4.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	135.71	43.25	18.45	10.12	4.56	5.56	2.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	154.34	44.66	18.24	11.69	6.08	8.89	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	144.11	31.52	18.87	7.05	3.73	7.88	6.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	151.09	49.11	18.58	12.39	4.87	9.51	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	156.66	41.78	15.46	10.86	3.13	6.06	4.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	158.00	35.80	21.26	8.48	6.86	6.33	5.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	195.33	40.53	19.07	15.50	4.43	4.43	3.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	169.27	44.54	15.23	13.11	5.01	8.48	1.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	149.07	40.92	20.80	6.53	5.85	11.52	5.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	174.89	36.35	16.73	12.48	4.39	5.90	2.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	145.78	43.50	25.28	9.52	4.43	8.54	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	164.47	41.76	20.45	6.99	3.24	9.20	3.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	154.02	39.65	21.90	13.32	4.44	9.03	3.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	134.34	40.25	19.99	8.53	4.00	5.33	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	212.65	32.63	13.55	13.27	4.01	7.33	6.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	150.96	37.14	20.95	9.52	3.33	9.29	2.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	209.40	41.52	21.56	13.91	5.44	5.44	3.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	163.77	29.10	14.31	7.35	3.77	8.57	3.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	162.10	45.07	18.87	6.29	2.79	24.46	4.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	173.77	36.57	11.79	13.90	2.12	2.72	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	133.16	30.35	18.48	9.67	2.81	7.71	3.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	231.14	33.91	31.00	19.07	5.82	3.49	4.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	153.93	32.25	20.08	9.13	3.04	7.91	4.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	133.82	25.32	15.67	3.92	1.51	6.63	4.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	147.25	33.70	19.90	11.76	2.71	14.48	3.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	176.13	31.15	25.46	9.29	4.19	11.08	3.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	144.88	26.21	23.02	11.45	3.07	5.79	5.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	192.53	36.50	26.25	14.30	2.35	4.27	4.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	217.55	39.66	24.64	11.42	3.61	4.21	0.60
Schwann Cells, donor1	11498-119F4	116.60	21.25	6.39	10.34	5.08	4.51	6.02
Schwann Cells, donor2	11578-120F3	44.23	13.61	3.40	0.00	10.21	3.40	10.21
Schwann Cells, donor3	11659-122F3	53.89	13.80	4.60	4.16	2.19	4.60	2.19
Sebocyte, donor1	11220-116B5	78.33	41.63	19.72	5.48	5.48	0.00	6.03
Sebocyte, donor2	11301-117B5	38.14	22.52	7.81	1.38	2.30	3.22	2.30
Sebocyte, donor3	11378-118B1	45.55	19.58	3.71	3.30	0.62	2.06	0.62
Sertoli Cells, donor1	11255-116F4	53.01	13.25	4.97	4.97	1.66	1.66	0.00
Sertoli Cells, donor2	11333-117F1	50.84	16.95	11.30	5.65	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	68.71	13.81	8.89	2.29	3.34	2.20	3.17
Skeletal Muscle Cells, donor2	11358-117H8	23.85	17.35	3.61	0.72	1.45	0.72	2.89
Skeletal Muscle Cells, donor3	11430-118G8	102.00	36.79	10.87	7.52	9.20	0.84	9.20
Skeletal Muscle Cells, donor4	11451-119A2	53.41	17.59	9.58	3.93	2.98	3.14	1.57
Skeletal Muscle Cells, donor5	11455-119A6	57.82	25.42	5.95	3.72	2.97	3.57	2.97
Skeletal Muscle Cells, donor6	11459-119B1	64.79	24.16	7.54	3.85	5.23	3.08	4.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	71.95	15.62	8.82	4.16	2.39	2.02	4.03
Skeletal Muscle Satellite Cells, donor2	11321-117D7	73.63	17.27	5.42	3.85	1.71	3.85	3.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	65.48	23.31	9.72	5.26	5.16	3.27	3.27
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	55.35	18.11	8.00	2.78	3.62	3.20	2.19
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	83.23	23.16	10.13	5.79	4.34	0.00	2.90
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	59.44	18.03	7.02	2.89	1.38	0.83	2.34
Skin - palm, donor1	10286-104F7	131.62	40.29	8.06	2.69	0.00	2.69	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	18.16	6.92	3.75	1.44	1.44	2.45	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	17.99	26.17	13.90	0.82	4.09	3.27	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	17.53	11.17	5.32	0.65	1.95	3.64	1.04
Small Airway Epithelial Cells, donor1	11256-116F5	20.85	8.06	5.84	2.09	2.92	1.53	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	32.21	13.08	7.17	1.97	2.53	1.41	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	31.08	14.80	14.17	4.44	1.90	1.90	5.29
Small Airway Epithelial Cells, donor3	11406-118E2	21.59	13.12	3.97	2.17	1.35	2.10	0.82
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	33.33	9.87	3.39	0.93	1.23	7.41	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	18.90	4.45	4.45	0.67	1.33	1.33	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	51.14	9.41	7.05	7.64	4.70	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	43.54	19.89	8.40	4.64	2.65	0.88	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	45.68	11.81	13.78	6.30	7.09	0.79	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	52.53	11.59	3.86	10.04	6.18	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	41.03	13.01	6.00	3.00	1.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	41.12	10.25	9.45	3.46	3.59	0.40	0.80
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	27.49	8.87	3.77	3.32	2.66	5.76	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	29.58	8.96	4.10	2.69	2.05	0.90	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	33.54	7.16	4.88	2.60	1.95	0.33	1.95
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	32.78	6.79	1.77	3.84	0.59	1.18	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	23.35	9.25	3.84	2.70	0.57	0.71	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	49.78	8.78	9.76	3.90	3.58	0.98	1.63
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	49.01	10.96	4.26	3.65	0.61	1.52	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	70.97	18.44	11.37	3.54	3.28	0.25	2.78
Smooth Muscle Cells - Carotid, donor2	11362-117I3	79.57	55.09	6.12	0.00	6.12	0.00	12.24
Smooth Muscle Cells - Carotid, donor3	11434-118H3	31.95	12.87	8.11	2.38	4.29	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	37.46	5.31	5.31	2.51	1.33	1.33	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	46.28	11.41	5.60	2.58	1.08	1.94	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	43.03	11.44	7.35	3.46	2.52	1.89	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	57.23	13.61	14.08	5.41	7.12	1.24	0.93
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	25.87	15.09	5.39	3.23	4.31	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	32.28	15.54	12.55	3.59	2.99	1.20	1.49
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	65.21	12.29	11.27	2.73	2.73	1.71	2.05
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	56.70	9.50	6.52	2.59	0.47	1.26	1.88
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	33.21	7.65	5.64	3.82	5.84	4.93	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	23.67	8.65	13.43	1.82	3.87	3.64	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	37.44	14.49	12.68	3.62	3.62	0.60	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	67.29	18.54	17.75	6.89	6.62	7.95	2.91
Smooth Muscle Cells - Prostate, donor1	11257-116F6	59.92	9.72	13.05	5.19	2.66	3.33	1.46
Smooth Muscle Cells - Prostate, donor2	11335-117F3	38.32	11.39	5.76	4.38	1.50	3.63	1.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	31.20	6.60	2.54	1.52	0.00	2.54	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	61.06	13.12	8.59	3.77	5.28	1.36	0.90
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	57.76	17.25	3.00	2.25	1.50	0.75	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	215.80	156.36	6.46	9.05	2.58	1.29	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	78.60	19.53	13.95	5.58	6.05	0.47	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	29.28	7.57	4.04	3.03	4.04	3.53	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	26.01	10.03	9.72	3.76	3.13	0.94	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	31.56	7.96	3.83	4.42	1.18	3.83	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	79.89	13.33	7.33	6.75	4.00	1.50	2.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	45.31	7.47	3.27	0.47	0.47	1.87	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	34.40	9.21	11.08	4.17	4.32	0.29	1.44
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	44.62	20.65	10.71	2.55	6.63	1.53	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	70.32	20.87	7.90	3.38	3.38	0.75	2.44
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	55.20	8.52	8.66	5.45	1.26	2.52	3.91
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	32.84	3.77	5.45	2.93	1.17	1.26	1.68
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	17.62	13.81	0.00	0.95	0.95	0.95	3.81
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	35.97	11.50	10.52	4.40	1.71	0.73	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	31.82	4.86	8.84	1.77	3.09	3.76	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	36.86	11.70	4.68	3.51	3.22	0.88	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	42.18	8.75	3.69	2.92	0.97	1.55	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	23.80	9.78	2.64	0.79	1.06	5.02	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	20.83	9.67	3.72	1.12	0.74	4.84	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	21.56	6.11	2.52	1.08	0.72	3.59	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	15.90	10.79	4.26	2.27	1.99	1.14	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	48.45	15.75	7.09	1.58	6.70	6.30	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	30.73	9.14	2.79	1.78	0.25	3.56	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	37.94	8.79	1.60	0.40	0.80	3.99	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	24.24	10.03	2.09	1.67	1.67	1.67	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	31.17	13.29	1.38	1.38	0.46	4.13	0.92
Synoviocyte, donor1	11291-117A4	31.48	7.24	4.04	0.84	2.36	4.21	0.50
Synoviocyte, donor2	11368-117I9	30.17	9.22	3.52	2.01	0.34	2.85	0.34
Synoviocyte, donor3	11440-118H9	45.13	11.39	6.03	2.01	0.22	6.48	1.34
Trabecular Meshwork Cells, donor1	11532-120A2	106.84	34.30	13.58	6.07	7.86	1.79	3.93
Trabecular Meshwork Cells, donor2	11612-122A1	43.60	17.84	1.98	0.00	5.95	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	70.16	20.84	4.63	2.55	3.47	0.69	1.85
Tracheal Epithelial Cells, donor1	11292-117A5	53.69	16.63	6.67	2.72	4.44	1.15	1.72
Tracheal Epithelial Cells, donor2	11369-118A1	34.02	14.69	5.41	0.77	2.71	0.00	1.55
Tracheal Epithelial Cells, donor3	11441-118I1	29.78	16.03	4.58	2.29	2.29	0.00	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	61.64	22.51	3.44	1.11	0.25	0.98	1.60
Urethra, donor2	10319-105A4	89.92	12.59	1.80	7.19	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	30.82	8.50	11.16	2.39	2.39	1.59	3.72
Urothelial Cells, donor2	11600-120H7	23.63	7.21	6.01	1.60	2.80	0.40	0.80
Urothelial Cells, donor3	11681-122H7	31.86	11.23	6.19	2.06	1.60	2.06	3.21
Urothelial cells, donor0	11216-116B1	37.89	10.70	8.25	2.01	2.23	1.11	3.12
Whole blood (ribopure), donor090309, donation1	12179-129A1	142.37	32.92	0.89	0.89	0.89	1.78	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	117.23	20.01	1.43	7.15	0.00	2.86	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	83.51	34.91	0.00	2.74	0.00	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	112.60	25.83	1.03	2.07	0.69	3.44	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	99.94	26.15	1.16	2.32	0.00	1.16	1.74
Whole blood (ribopure), donor090612, donation1	12182-129A4	123.91	21.87	0.00	0.00	1.04	1.04	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	122.07	30.29	1.84	3.67	0.00	3.67	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	85.81	56.60	0.00	2.74	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	45.03	19.00	8.64	3.08	4.07	4.81	3.45
Wilms' tumor cell line:HFWT	10597-108E3	51.04	37.84	0.88	1.76	0.00	0.00	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	40.50	17.32	1.40	1.12	1.68	1.68	2.79
achilles tendon, donor2	10292-104G4	57.86	16.53	2.07	0.00	0.00	4.13	6.20
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	157.82	38.50	7.14	7.14	4.33	13.26	5.86
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	130.48	44.58	3.48	2.55	4.18	6.04	6.73
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	235.16	40.00	5.10	9.97	5.10	6.41	10.57
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	145.85	47.62	3.81	7.07	6.80	13.88	7.07
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	97.82	51.72	2.25	5.34	3.37	14.34	9.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	91.57	19.24	2.75	3.81	1.27	1.90	4.65
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	145.09	66.69	7.35	8.44	10.07	7.89	9.26
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	44.50	32.17	7.49	2.20	6.61	2.64	6.61
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	88.61	27.36	3.68	3.27	1.23	4.49	5.31
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	91.25	24.46	6.60	7.38	2.72	5.05	5.44
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	62.01	39.56	6.62	2.02	4.23	6.44	5.70
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	105.31	23.40	7.80	3.90	7.80	3.90	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	76.92	39.27	8.37	2.09	2.56	4.88	8.13
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	175.54	75.86	13.46	8.80	12.95	12.95	8.54
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	85.92	39.45	7.31	4.97	5.84	12.27	7.60
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	106.89	44.15	6.04	6.04	3.72	1.86	3.25
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	108.98	106.51	1.23	4.11	5.76	8.23	4.94
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	57.40	25.17	5.22	3.07	3.38	8.59	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	109.24	47.79	17.50	7.68	4.69	3.84	5.55
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	114.95	39.73	13.04	7.58	4.25	3.94	7.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	118.67	44.05	24.79	6.98	9.15	4.33	7.46
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	61.25	56.58	3.12	2.90	4.01	5.57	6.46
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	70.71	47.70	9.34	3.00	7.34	5.00	3.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	375.36	111.49	1.86	9.29	1.86	0.00	5.57
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	107.72	48.59	6.03	10.92	9.42	4.90	5.65
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	102.06	65.86	2.18	4.36	3.05	2.62	6.11
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	329.91	46.86	1.87	63.73	3.75	3.75	5.62
adenocarcinoma cell line:IM95m	10796-110I4	42.39	28.73	2.12	0.94	1.41	1.41	2.35
adipose tissue, adult, pool1	10010-101C1	70.11	17.06	2.02	1.71	0.62	0.78	1.09
adipose, donor1	10184-103D4	84.44	22.87	10.56	7.62	2.93	9.97	6.45
adipose, donor2	10185-103D5	48.26	5.27	1.22	3.24	0.00	4.06	1.22
adipose, donor3	10186-103D6	67.26	17.15	2.18	4.36	1.91	3.81	1.36
adipose, donor4	10187-103D7	127.41	52.01	2.60	13.00	6.93	9.53	9.53
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	50.03	32.98	1.42	1.58	3.47	1.42	9.15
adrenal gland, adult, pool1	10081-102A9	54.57	10.91	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	75.64	31.48	2.93	2.40	1.87	2.00	2.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	40.73	26.80	5.72	3.57	2.86	4.64	3.93
amniotic membrane cells, donor1	12235-129G3	46.83	13.22	1.16	0.93	0.70	0.46	3.71
amniotic membrane cells, donor2	12236-129G4	80.47	20.96	3.72	1.69	0.68	3.72	2.37
amniotic membrane cells, donor3	12237-129G5	73.94	17.09	0.59	1.18	0.29	0.29	2.95
amygdala - adult, donor10196	10167-103B5	35.57	15.42	0.00	3.56	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	91.45	20.68	0.61	2.64	0.41	1.62	0.00
amygdala, newborn, donor10223	10360-105E9	32.60	15.82	1.61	1.29	0.32	2.26	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	88.88	11.33	11.08	5.60	1.53	1.91	4.07
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	53.17	33.53	12.13	3.97	8.60	6.18	3.53
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	133.95	11.69	8.68	7.35	0.33	1.67	7.68
aorta, adult, pool1	10052-101G7	78.65	18.24	2.16	2.55	0.78	1.57	1.57
appendix, adult	10189-103D9	98.58	41.14	4.66	4.66	0.78	2.72	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	65.35	23.04	3.78	3.44	4.82	2.75	1.38
artery, adult	10190-103E1	88.31	14.95	1.36	0.00	0.00	6.79	1.36
astrocytoma cell line:TM-31	10425-106D2	74.61	19.12	17.38	4.93	7.10	2.03	1.59
b cell line:RPMI1788	10427-106D4	75.09	31.67	5.06	1.34	3.42	2.38	2.83
basal cell carcinoma cell line:TE 354.T	10702-109G9	23.58	4.99	5.55	2.22	2.22	2.50	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	74.13	17.17	15.98	5.06	6.95	1.39	3.77
bile duct carcinoma cell line:TFK-1	10496-107C1	45.36	24.94	0.84	1.67	2.01	2.18	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	112.41	33.55	10.63	6.15	1.68	5.59	5.03
bladder, adult, pool1	10011-101C2	122.33	14.78	3.37	4.13	0.22	1.30	1.20
blood, adult, pool1	10053-101G8	68.65	19.93	0.00	0.00	0.00	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	84.78	13.70	6.85	7.71	1.71	0.86	0.86
bone marrow, adult	10192-103E3	77.60	36.44	4.72	0.00	2.02	13.50	2.02
brain, adult, donor1	10084-102B3	68.68	13.33	0.00	0.00	0.00	2.05	3.08
brain, adult, pool1	10012-101C3	74.94	12.92	0.33	2.67	0.11	2.45	0.67
brain, fetal, pool1	10085-102B4	130.90	21.37	0.00	5.34	0.00	10.69	0.00
breast carcinoma cell line:MCF7	10482-107A5	150.65	41.96	0.99	4.63	0.00	3.63	3.63
breast carcinoma cell line:MDA-MB-453	10419-106C5	101.98	35.95	9.49	2.37	2.75	1.62	3.50
breast, adult, donor1	10080-102A8	51.14	20.20	1.89	1.89	0.00	1.26	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	52.09	19.18	3.30	1.02	0.89	3.56	4.32
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	99.57	19.48	21.65	2.78	1.55	2.78	7.42
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	52.95	25.78	1.61	0.46	0.92	10.13	5.76
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	66.82	31.96	5.33	1.21	2.18	4.12	3.87
carcinoid cell line:NCI-H1770	10703-109H1	102.97	34.79	6.11	6.58	2.82	8.93	3.29
carcinoid cell line:NCI-H727	10735-110B6	72.41	23.08	7.33	4.92	2.95	0.98	4.92
carcinoid cell line:SK-PN-DW	10719-109I8	91.90	25.03	2.54	5.07	4.75	7.29	2.85
carcinosarcoma cell line:JHUCS-1	10642-109A3	149.06	64.15	6.12	5.86	3.46	9.05	3.19
caudate nucleus - adult, donor10196	10177-103C6	51.81	8.06	1.15	3.45	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	71.78	18.91	0.33	1.34	0.33	1.17	0.67
caudate nucleus, adult, donor10258	10379-105H1	55.78	12.23	0.00	4.58	1.53	1.53	0.76
caudate nucleus, newborn, donor10223	10354-105E3	47.24	15.02	1.10	1.10	2.93	2.20	0.37
cerebellum - adult, donor10196	10173-103C2	58.27	26.22	0.00	2.91	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	106.54	34.80	1.07	3.42	0.00	1.49	1.28
cerebellum, adult, pool1	10083-102B2	61.40	20.01	0.34	1.03	0.00	4.14	0.34
cerebellum, newborn, donor10223	10357-105E6	112.09	45.67	2.49	0.83	0.00	4.15	0.83
cerebral meninges, adult	10188-103D8	57.24	17.40	0.50	3.28	0.25	1.51	0.76
cerebrospinal fluid, donor2	10294-104G6	41.66	16.08	0.00	1.46	0.00	2.92	0.73
cervical cancer cell line:D98-AH2	10552-107I3	39.11	15.82	3.59	0.86	3.02	2.88	5.90
cervical cancer cell line:ME-180	10553-107I4	61.98	24.36	10.27	2.49	3.81	1.99	1.82
cervix, adult, pool1	10013-101C4	145.41	22.05	3.15	4.93	0.84	2.83	1.99
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	74.55	18.67	3.76	8.78	2.37	3.34	1.39
chondrosarcoma cell line:SW 1353	10700-109G7	44.41	13.06	2.61	2.61	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	42.01	13.30	1.49	1.37	2.11	3.36	5.34
choriocarcinoma cell line:SCH	10785-110H2	57.05	44.97	7.64	2.09	15.16	6.65	9.73
choriocarcinoma cell line:T3M-3	10618-108G6	14.94	24.19	0.71	0.24	3.79	0.95	4.03
chorionic membrane cells, donor1	12238-129G6	32.77	11.97	1.99	0.85	0.00	1.71	1.99
chorionic membrane cells, donor2	12239-129G7	46.93	16.11	15.81	4.87	3.18	1.39	1.99
chorionic membrane cells, donor3	12240-129G8	39.01	13.74	1.65	0.00	0.55	3.85	5.49
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	47.46	39.38	3.03	1.01	4.04	3.03	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	89.90	39.38	8.45	6.34	2.88	4.61	5.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	112.14	28.51	16.26	8.45	4.43	4.65	7.18
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	38.52	31.59	2.05	0.26	5.91	1.54	3.34
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	52.97	40.15	4.11	0.73	7.50	2.18	4.84
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	42.76	34.00	6.72	0.61	5.09	1.43	5.09
chronic myelogenous leukemia cell line:K562	10454-106G4	47.41	26.80	2.94	0.29	8.54	4.12	5.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	249.42	44.83	14.86	17.20	8.60	5.73	12.77
clear cell carcinoma cell line:JHOC-5	10638-108I8	55.32	31.32	7.77	1.83	1.37	7.09	6.17
clear cell carcinoma cell line:TEN	10636-108I6	20.13	5.73	3.30	0.52	2.26	2.08	5.55
colon carcinoma cell line:CACO-2	10513-107D9	96.83	23.61	7.32	4.03	2.01	3.11	6.77
colon carcinoma cell line:COLO-320	10420-106C6	93.12	43.33	7.98	2.28	5.32	2.28	13.30
colon, adult, donor1	10082-102B1	77.35	20.23	2.38	1.19	0.00	2.38	0.00
colon, adult, pool1	10014-101C5	117.74	27.61	4.00	3.76	0.47	1.06	4.11
colon, fetal, donor1	10070-101I7	69.21	23.48	1.24	1.24	0.62	3.71	3.71
common myeloid progenitor CMP, donor1	12130-128D6	210.84	32.08	0.00	27.50	9.17	0.00	9.17
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	31.02	32.29	5.95	2.12	3.82	2.55	2.12
cord blood derived cell line:COBL-a 24h infection	10453-106G3	37.58	24.45	11.77	1.81	2.72	1.96	2.72
cord blood derived cell line:COBL-a untreated	10449-106F8	43.85	31.30	16.78	1.27	5.22	3.24	3.67
corpus callosum, adult, pool1	10042-101F6	169.38	20.01	0.77	4.64	0.44	1.00	1.55
cruciate ligament, donor2	10295-104G7	57.54	13.78	2.43	0.81	0.00	4.86	1.62
diaphragm, fetal, donor1	10069-101I6	79.45	8.03	0.80	4.82	0.00	5.62	0.80
diencephalon, adult	10193-103E4	52.56	10.08	0.00	1.20	0.00	1.92	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	103.78	48.22	7.58	5.51	4.59	7.81	8.50
ductal cell carcinoma cell line:KLM-1	10438-106E6	44.36	22.31	6.15	1.28	7.95	0.77	4.36
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	39.00	3.13	12.76	7.22	4.57	4.09	2.41
ductus deferens, adult	10196-103E7	81.73	24.42	2.49	1.99	1.50	4.98	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	54.73	18.72	0.00	2.88	0.00	5.76	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	79.45	40.46	0.74	2.21	0.00	5.89	3.68
dura mater, adult, donor1	10041-101F5	136.27	27.01	7.02	6.44	1.73	1.65	0.83
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	93.71	23.54	6.22	10.44	16.43	4.00	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	167.51	21.06	6.73	15.19	9.46	5.88	2.15
embryonic pancreas cell line:1B2C6	10604-108F1	53.03	30.83	6.17	1.85	1.85	0.62	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	29.97	13.92	7.27	1.21	2.72	2.12	3.03
embryonic pancreas cell line:1C3IKEI	10606-108F3	24.70	22.54	9.26	0.62	2.16	1.54	1.54
embryonic pancreas cell line:2C6	10603-108E9	51.23	30.21	14.45	7.88	5.25	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	190.39	30.84	28.83	12.74	4.02	5.36	7.04
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	66.33	24.10	5.62	1.99	2.72	8.34	5.44
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	17.21	13.83	5.79	0.80	3.54	1.45	1.93
epidermoid carcinoma cell line:A431	10426-106D3	138.73	28.79	9.89	9.34	4.78	1.67	3.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	124.83	30.36	6.05	8.14	7.37	4.18	3.96
epididymis, adult	10197-103E8	74.10	16.95	4.19	2.30	1.26	2.93	1.88
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	64.40	21.29	3.90	3.90	2.66	4.44	1.60
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	53.87	17.30	7.47	4.72	3.54	0.79	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	24.90	27.78	12.19	1.31	6.68	3.80	3.15
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	26.38	21.75	7.87	1.48	7.87	2.56	2.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	29.24	23.30	10.42	1.68	7.95	4.03	4.15
esophagus, adult, pool1	10015-101C6	82.61	22.09	2.12	2.02	1.38	1.17	1.81
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	82.03	27.05	10.90	1.63	2.25	0.88	5.39
eye - muscle inferior rectus, donor1	10272-104E2	65.19	16.90	7.24	0.00	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	46.29	16.83	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	72.92	28.28	1.49	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	44.71	17.20	0.00	1.15	1.15	3.44	1.15
eye - vitreous humor, donor1	10268-104D7	59.75	18.95	2.91	4.37	0.00	1.46	1.46
eye, fetal, donor1	10054-101G9	88.98	20.85	0.76	6.10	0.00	4.83	1.53
fibrosarcoma cell line:HT-1080	10758-110E2	54.50	14.75	4.10	5.26	4.36	3.46	6.28
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	37.51	18.28	7.83	3.32	8.07	1.90	4.99
frontal lobe, adult, pool1	10040-101F4	81.16	10.13	0.38	2.44	0.19	1.31	1.13
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	154.93	19.22	18.62	12.61	5.40	15.01	3.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	61.81	20.12	2.19	2.65	1.83	1.01	4.66
gall bladder, adult	10198-103E9	91.50	26.07	3.86	2.17	0.48	1.21	1.45
gamma delta positive T cells, donor1	11937-126A2	117.57	26.31	2.15	2.15	0.00	2.15	1.61
gamma delta positive T cells, donor2	11938-126A3	107.94	32.87	1.12	4.11	0.75	3.36	2.24
gastric adenocarcinoma cell line:MKN1	10614-108G2	61.25	22.18	5.91	3.80	2.11	4.22	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	67.70	29.79	13.15	4.84	1.74	3.67	12.38
gastric cancer cell line:AZ521	10549-107H9	60.99	37.55	3.28	1.64	6.07	4.43	3.77
gastric cancer cell line:GSS	10560-108A2	94.27	38.44	5.49	1.83	2.75	1.83	4.58
gastrointestinal carcinoma cell line:ECC12	10615-108G3	112.63	38.15	5.25	6.17	1.60	5.03	4.34
giant cell carcinoma cell line:LU65	10487-107B1	19.74	16.98	4.59	0.92	8.95	3.44	3.79
giant cell carcinoma cell line:Lu99B	10433-106E1	68.44	11.34	13.16	5.04	3.36	1.54	5.32
glassy cell carcinoma cell line:HOKUG	10688-109F4	59.36	40.41	7.48	2.00	4.99	4.74	2.49
glioblastoma cell line:A172, tech_rep1	10444-106F3	91.72	33.88	9.39	5.81	6.02	2.32	2.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	94.09	32.86	9.13	9.97	4.77	3.37	3.09
glioblastoma cell line:T98G	10485-107A8	69.31	26.38	12.69	4.41	2.87	2.32	3.86
glioma cell line:GI-1	10413-106B8	78.78	23.14	5.27	4.98	2.05	2.64	4.39
globus pallidus - adult, donor10196	10175-103C4	63.42	11.66	0.00	4.37	1.46	1.46	0.00
globus pallidus, adult, donor10252	10161-103A8	128.39	21.48	0.73	2.69	0.98	0.49	1.46
globus pallidus, adult, donor10258	10367-105F7	46.55	8.22	0.00	0.00	0.00	2.74	1.37
globus pallidus, newborn, donor10223	10364-105F4	38.90	15.45	1.07	1.60	1.07	1.07	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	249.61	61.18	9.79	31.81	7.34	0.00	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	21.86	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	62.72	5.23	0.00	5.23	0.00	5.23	5.23
granulosa cell tumor cell line:KGN	10624-108H3	54.40	21.76	4.80	3.52	2.24	1.92	0.32
hIPS +CCl2, biol_rep1	14383-156B9	51.42	28.01	9.64	0.92	14.23	5.97	4.13
hIPS +CCl2, biol_rep2	14384-156C1	60.36	23.32	11.89	1.83	15.55	5.94	2.74
hIPS +CCl2, biol_rep3	14385-156C2	56.04	31.56	3.22	3.22	15.46	2.58	1.29
hIPS, biol_rep1	14380-156B6	15.81	14.37	7.19	0.00	24.43	0.00	1.44
hIPS, biol_rep2	14381-156B7	46.64	17.15	0.69	0.69	10.97	2.74	2.06
hIPS, biol_rep3	14382-156B8	47.45	19.86	1.10	3.31	0.00	3.31	1.10
hairy cell leukemia cell line:Mo	10712-109I1	52.30	35.63	7.18	2.01	2.87	3.16	2.01
heart - mitral valve, adult	10205-103F7	82.52	17.94	0.60	2.39	0.00	1.20	1.20
heart - pulmonic valve, adult	10206-103F8	109.04	18.30	0.78	3.66	0.00	3.40	1.83
heart - tricuspid valve, adult	10207-103F9	60.78	29.14	2.50	1.67	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	76.52	32.24	2.04	2.65	2.04	8.16	2.04
heart, adult, diseased, donor1	10051-101G6	81.33	13.63	2.98	4.68	0.00	5.54	0.85
heart, adult, pool1	10016-101C7	123.73	18.86	1.61	5.75	0.00	0.23	0.46
heart, fetal, pool1	10046-101G1	143.65	18.17	2.88	5.85	0.41	1.44	3.29
hepatic mesenchymal tumor cell line:LI90	10778-110G4	45.97	7.71	6.48	2.78	0.62	1.54	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	96.32	32.11	5.95	2.38	1.19	1.19	8.32
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	79.23	25.97	13.70	4.75	3.76	3.43	3.20
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	85.08	22.21	14.93	6.07	5.46	4.13	3.64
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	90.95	24.56	16.37	5.05	6.77	2.83	3.23
hepatoma cell line:Li-7	10484-107A7	57.61	22.02	7.90	4.00	3.34	2.34	2.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	55.07	24.52	5.33	2.31	4.92	4.72	7.04
hippocampus - adult, donor10196	10169-103B7	50.16	10.41	0.95	2.84	0.00	1.89	0.95
hippocampus, adult, donor10252	10153-102I9	95.52	23.88	0.61	2.86	0.82	1.02	0.61
hippocampus, adult, donor10258	10374-105G5	32.86	9.46	0.00	1.00	0.50	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	40.53	14.10	0.35	1.06	0.70	1.06	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	74.46	35.40	9.16	3.66	17.09	14.04	9.77
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	47.91	15.51	3.73	2.95	6.09	4.32	5.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	59.16	22.34	2.54	3.81	9.14	7.87	7.36
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	68.79	12.41	5.07	3.38	2.26	7.89	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	68.43	14.72	4.65	3.61	2.58	18.85	3.36
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	88.07	18.98	5.31	1.90	3.80	5.69	4.56
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	81.16	16.06	5.26	2.04	1.17	4.96	3.50
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	77.55	13.14	2.59	5.60	0.86	4.95	5.60
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	67.98	18.77	6.26	1.25	1.25	1.67	2.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	54.94	11.84	7.81	2.37	4.26	1.18	4.74
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	74.41	19.29	4.98	3.54	2.89	2.57	3.54
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	68.00	14.81	6.73	3.37	2.02	2.02	8.08
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	50.08	19.25	2.35	2.50	5.16	4.07	4.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	38.32	25.55	3.93	1.47	3.93	11.79	4.91
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	59.35	32.29	4.36	2.62	10.47	4.36	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	85.72	15.65	5.54	4.77	1.15	5.54	4.39
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	68.03	11.34	6.11	3.92	3.49	6.11	3.05
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	72.47	24.99	6.50	3.00	2.00	10.99	8.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	66.88	10.55	3.58	3.58	0.75	4.52	4.52
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	67.75	10.91	1.82	3.18	0.91	6.82	6.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	80.19	11.28	2.19	2.19	0.31	3.45	3.76
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	51.93	11.59	4.90	1.80	0.65	2.61	1.96
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	54.29	12.19	4.06	2.32	1.45	3.48	4.35
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	65.46	11.96	3.29	2.39	2.69	3.89	5.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	48.96	17.55	3.14	2.77	9.24	7.02	4.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	40.51	17.12	6.56	3.71	11.13	5.42	4.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	69.00	28.99	5.31	3.67	13.07	10.62	9.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	51.05	22.89	6.69	1.76	4.93	5.99	6.34
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	57.01	10.45	4.75	3.48	3.48	3.48	2.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	65.06	18.46	5.45	2.72	5.14	3.33	2.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	47.58	13.45	5.69	2.07	1.03	4.14	3.10
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	41.84	14.61	3.98	3.98	0.00	1.99	3.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	64.90	14.62	6.67	1.28	2.05	0.26	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	57.78	15.85	5.62	3.32	4.09	3.32	3.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	68.15	12.87	6.82	0.76	2.27	2.27	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	56.12	10.75	5.71	2.02	2.35	5.04	2.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	48.30	16.42	5.31	0.72	12.80	4.59	8.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	61.06	18.27	2.23	1.78	16.49	6.68	6.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	49.76	24.39	1.95	2.93	6.34	8.29	4.88
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	59.29	17.42	7.95	1.53	3.67	4.28	4.28
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	120.37	74.82	48.80	6.51	6.51	16.27	35.79
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	85.71	23.50	10.92	5.63	5.63	5.63	8.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	74.98	14.78	4.93	3.83	3.28	3.28	7.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	65.14	9.05	5.79	4.34	2.90	3.26	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	64.41	13.52	4.98	1.78	1.07	5.69	6.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	41.77	13.13	2.39	0.00	2.39	5.97	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	78.95	17.47	8.67	4.74	2.03	3.93	6.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	55.50	11.05	2.69	3.23	1.35	3.50	1.62
immature langerhans cells, donor1	11904-125F5	101.94	39.47	7.99	7.75	6.30	1.21	0.48
immature langerhans cells, donor2	11905-125F6	51.49	15.84	7.13	0.79	1.58	1.58	0.00
insula, adult, pool1	10039-101F3	84.22	12.40	1.04	3.22	0.76	1.51	0.57
keratoacanthoma cell line:HKA-1	10791-110H8	25.69	10.73	1.95	1.63	1.63	0.33	0.65
kidney, adult, pool1	10017-101C8	53.77	13.62	3.70	1.90	0.40	1.60	2.20
kidney, fetal, pool1	10045-101F9	112.61	23.91	5.02	3.11	1.27	0.85	5.73
large cell lung carcinoma cell line:IA-LM	10509-107D5	72.86	9.66	10.94	8.52	6.11	0.99	2.70
large cell lung carcinoma cell line:NCI-H460	10839-111E2	19.77	10.09	2.63	0.55	0.83	0.83	1.94
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	71.93	18.35	20.18	5.50	6.24	2.02	4.04
left atrium, adult, donor1	10079-102A7	37.05	11.99	1.09	1.63	0.00	4.90	2.72
left ventricle, adult, donor1	10078-102A6	56.13	7.58	1.52	3.03	0.51	2.02	0.00
leiomyoblastoma cell line:G-402	10721-110A1	62.38	29.00	7.11	5.75	3.01	1.09	2.19
leiomyoma cell line:10964C	10569-108B2	21.55	4.67	1.44	1.80	0.36	1.44	0.00
leiomyoma cell line:15242A	10570-108B3	17.39	5.43	3.80	0.00	1.63	1.09	0.00
leiomyoma cell line:15425	10571-108B4	24.77	10.20	6.31	3.16	0.97	2.67	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	178.79	47.05	52.28	29.28	19.87	5.23	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	152.06	24.79	13.10	12.28	5.31	5.31	8.26
liposarcoma cell line:KMLS-1	10782-110G8	27.81	9.22	3.75	2.19	0.16	2.19	1.41
liposarcoma cell line:SW 872	10726-110A6	75.30	14.74	8.77	5.12	2.44	1.58	1.95
liver, adult, pool1	10018-101C9	33.55	15.23	4.70	1.62	1.62	0.81	1.30
liver, fetal, pool1	10086-102B5	22.58	14.11	0.00	0.94	0.00	1.88	0.94
locus coeruleus - adult, donor10196	10182-103D2	63.58	9.77	0.29	3.50	0.15	0.58	0.44
locus coeruleus, adult, donor10252	10165-103B3	74.00	13.84	0.37	2.95	0.37	1.85	1.48
locus coeruleus, adult, donor10258	10375-105G6	38.37	8.75	0.85	1.69	0.00	1.41	0.00
locus coeruleus, newborn, donor10223	10362-105F2	49.63	23.98	2.52	1.26	2.10	1.26	1.26
lung adenocarcinoma cell line:A549	10499-107C4	62.00	27.40	3.04	1.94	1.25	0.83	5.26
lung adenocarcinoma cell line:PC-14	10408-106B3	64.80	40.67	8.27	4.83	4.14	0.00	4.14
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	76.72	21.75	2.37	3.82	1.32	1.32	3.56
lung, adult, pool1	10019-101D1	75.48	14.77	4.73	3.54	1.30	1.06	1.65
lung, fetal, donor1	10068-101I5	172.96	41.10	8.56	7.71	1.71	1.43	11.13
lung, right lower lobe, adult, donor1	10075-102A3	60.03	16.95	1.83	1.37	0.00	8.25	1.83
lymph node, adult, donor1	10077-102A5	73.84	26.03	2.84	0.95	0.47	8.99	1.42
lymphangiectasia cell line:DS-1	10727-110A7	51.73	30.03	7.23	2.85	6.79	3.51	2.63
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	97.50	37.73	8.60	4.98	3.62	4.08	3.47
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	56.92	31.43	4.25	1.70	7.65	0.85	0.85
mature adipocyte, donor1	12231-129F8	74.15	21.76	0.89	3.11	0.89	0.00	0.89
mature adipocyte, donor2	12232-129F9	64.33	18.47	0.42	1.87	0.42	0.62	0.83
mature adipocyte, donor3	12233-129G1	52.63	15.88	1.19	0.71	0.24	0.24	0.95
mature adipocyte, donor4	12234-129G2	89.49	20.53	1.84	2.37	0.79	0.53	1.58
maxillary sinus tumor cell line:HSQ-89	10414-106B9	43.36	22.63	5.00	1.67	5.96	1.91	10.25
medial frontal gyrus - adult, donor10196	10170-103B8	55.27	7.90	0.00	1.13	0.00	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	87.72	15.45	1.10	2.21	0.55	1.66	1.10
medial frontal gyrus, adult, donor10258	10368-105F8	40.66	11.44	0.00	0.95	0.32	1.27	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	42.65	29.00	0.85	1.28	1.28	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	61.59	21.26	0.17	1.35	0.17	12.83	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	85.53	19.95	1.06	3.40	0.00	1.91	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	9.63	3.85	0.00	0.00	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	71.77	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	34.82	14.00	0.72	2.15	0.72	1.08	0.00
medulla oblongata - adult, donor10196	10174-103C3	38.94	8.44	0.65	3.89	0.65	2.60	1.95
medulla oblongata, adult, donor10252	10155-103A2	84.99	14.55	0.93	2.48	0.31	1.39	1.08
medulla oblongata, adult, pool1	10038-101F2	104.32	12.00	1.14	4.90	0.41	1.22	1.06
medulla oblongata, newborn, donor10223	10361-105F1	54.85	17.01	0.69	0.69	0.69	4.17	0.35
medulloblastoma cell line:D283 Med	10838-111E1	125.98	33.65	9.52	5.31	6.20	8.64	10.18
medulloblastoma cell line:ONS-76	10759-110E3	132.79	17.00	6.24	12.59	3.55	3.67	6.97
melanoma cell line:COLO 679	10514-107E1	48.44	10.92	3.88	2.73	1.58	1.44	0.86
melanoma cell line:G-361	10465-106H6	41.53	18.19	7.60	2.99	1.90	8.42	4.34
meningioma cell line:HKBMM	10691-109F7	26.95	12.12	7.96	1.99	0.54	1.81	1.27
merkel cell carcinoma cell line:MKL-1	10843-111E6	226.46	41.41	7.05	15.86	2.64	21.15	5.29
merkel cell carcinoma cell line:MS-1	10844-111E7	153.72	29.81	5.44	9.33	3.37	5.18	5.18
mesenchymal precursor cell - adipose, donor1	11747-123G1	53.40	15.80	8.59	2.61	3.99	2.61	3.22
mesenchymal precursor cell - adipose, donor2	11748-123G2	44.72	15.09	7.82	3.27	1.09	1.45	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	40.17	14.08	7.04	0.83	4.14	2.48	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	36.52	10.25	4.64	2.67	1.26	1.55	0.98
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	36.20	10.98	5.20	2.70	1.35	0.77	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	31.23	13.19	7.63	2.08	2.08	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	28.83	10.13	2.06	1.72	1.72	0.00	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	40.49	16.45	5.18	2.42	2.19	1.38	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	53.85	16.45	5.70	4.11	1.59	2.39	1.19
mesenchymal precursor cell - cardiac, donor4	11755-123G9	43.48	14.99	8.78	5.27	2.97	1.49	1.62
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	40.12	13.80	11.81	3.27	3.70	0.43	1.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	26.02	10.21	2.63	1.65	1.32	1.65	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	37.08	10.38	9.69	4.01	2.63	1.11	1.38
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	38.40	15.36	5.24	1.40	1.75	1.75	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	25.93	5.72	5.92	2.86	2.45	1.22	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	17.97	8.99	5.75	1.80	1.80	2.16	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	31.14	6.93	4.55	1.76	0.52	1.66	0.62
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	12.77	6.16	6.61	1.14	0.68	1.14	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	56.22	11.75	14.26	3.36	3.36	4.62	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	33.32	11.81	8.22	3.74	2.24	1.05	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	35.45	11.90	6.48	2.63	1.58	2.19	1.31
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	23.93	9.20	3.68	1.84	1.84	0.37	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	21.18	7.73	9.16	2.00	4.29	1.72	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	57.26	22.31	10.53	5.05	6.32	7.16	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	45.21	6.85	1.83	2.74	0.46	2.28	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	46.30	13.05	4.86	1.79	1.02	2.30	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	47.12	11.26	3.66	3.66	1.83	2.36	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	49.91	15.71	2.46	1.85	0.62	1.23	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	39.54	11.77	3.29	0.94	1.41	1.18	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	48.06	12.86	6.09	1.02	1.02	2.03	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	48.34	14.54	5.11	1.18	0.79	3.14	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	55.61	16.22	4.17	0.93	0.00	3.24	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	52.20	13.27	6.92	2.60	0.87	1.73	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	44.62	13.39	3.35	1.34	1.78	2.45	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	52.16	10.58	5.77	1.44	1.20	1.92	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	66.73	22.00	5.13	5.87	0.00	4.40	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	52.36	9.73	3.36	4.36	1.01	1.34	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	50.35	17.19	5.32	1.23	0.82	1.64	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	40.81	13.32	3.01	1.29	1.72	3.87	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	38.28	24.61	0.00	5.47	2.73	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	25.82	15.49	0.00	0.00	10.33	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	52.62	16.56	4.87	1.95	1.30	2.27	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	50.92	21.82	4.36	1.45	1.45	2.91	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	44.25	14.93	1.60	2.67	2.13	1.60	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	47.43	13.90	4.09	0.00	0.82	4.09	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	47.81	11.66	5.05	1.17	0.78	2.33	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	54.57	18.89	4.20	0.00	6.30	10.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	52.65	17.88	2.98	2.98	1.99	3.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	14.30	4.77	0.00	4.77	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	53.37	14.23	3.56	1.19	0.59	0.59	1.78
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	58.49	12.18	3.66	3.66	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	27.05	0.00	0.00	0.00	27.05	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	52.57	8.87	3.80	3.17	1.90	4.43	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	44.49	11.73	2.07	3.45	0.34	1.72	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	47.28	10.75	4.30	0.00	0.00	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	7.98	0.00	0.00	0.00	15.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	17.22	3.44	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	30.15	3.67	2.04	1.63	0.81	0.41	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	35.75	7.94	1.59	0.79	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	25.35	6.48	4.13	0.59	0.00	2.95	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	33.04	7.79	2.18	0.31	0.31	1.56	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	48.12	6.68	4.01	0.00	1.34	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	37.85	5.91	7.10	2.37	1.18	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	38.52	7.70	2.57	0.00	0.00	7.70	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	39.93	8.26	6.88	1.38	0.69	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	27.21	9.90	2.47	0.49	1.48	1.98	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	20.19	12.34	0.00	1.12	1.12	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	27.99	10.18	1.27	0.64	1.27	5.09	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	18.13	6.04	0.40	0.40	0.81	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	21.81	15.26	0.00	0.00	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	26.61	6.34	0.00	2.53	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	20.63	11.53	2.43	0.00	0.61	1.21	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	22.59	18.08	0.00	0.00	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	17.30	13.18	0.82	0.82	0.00	2.47	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	24.41	6.35	1.59	0.99	0.79	0.60	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	22.71	7.79	3.57	0.97	1.30	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	32.60	6.11	3.06	7.13	1.02	3.06	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	82.01	30.17	5.42	3.87	0.77	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	19.84	18.19	3.54	0.47	3.54	0.00	2.60
mesothelioma cell line:ACC-MESO-4	10494-107B8	141.09	26.18	31.04	11.12	11.35	5.56	2.32
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	81.20	8.55	25.64	12.82	12.82	12.82	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	50.66	12.84	7.30	6.06	9.45	4.32	0.31
mesothelioma cell line:Mero-25	10850-111F4	33.82	12.26	10.89	4.09	9.08	4.99	2.04
mesothelioma cell line:Mero-41	10851-111F5	51.34	36.43	20.54	1.71	4.40	4.65	0.73
mesothelioma cell line:Mero-48a	10852-111F6	40.08	13.06	6.42	1.77	3.54	2.21	0.89
mesothelioma cell line:Mero-82	10853-111F7	59.13	11.56	12.35	8.41	5.52	10.78	0.26
mesothelioma cell line:Mero-83	10854-111F8	78.64	19.06	14.81	6.47	4.77	4.94	1.36
mesothelioma cell line:Mero-84	10855-111F9	60.41	20.47	6.32	2.27	2.27	2.78	2.02
mesothelioma cell line:Mero-95	10856-111G1	51.55	14.08	10.15	1.24	2.90	3.93	1.86
mesothelioma cell line:NCI-H2052	10847-111F1	50.85	12.42	9.94	3.64	8.28	4.80	1.16
mesothelioma cell line:NCI-H226	10846-111E9	40.18	15.02	8.87	4.71	3.98	4.16	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	28.36	11.45	9.40	1.88	2.56	2.22	2.39
mesothelioma cell line:NCI-H28	10845-111E8	39.95	24.43	9.67	2.54	2.80	5.85	2.04
mesothelioma cell line:No36	10857-111G2	55.78	15.01	4.57	0.98	4.57	4.57	4.57
mesothelioma cell line:ONE58	10858-111G3	23.57	4.88	9.75	1.63	4.06	4.06	0.54
migratory langerhans cells, donor1	11901-125F2	19.38	33.97	3.65	0.19	1.15	1.54	1.54
migratory langerhans cells, donor2	11902-125F3	32.12	31.51	3.54	0.24	0.24	1.47	2.32
migratory langerhans cells, donor3	11903-125F4	55.46	33.38	2.51	0.90	0.18	1.26	2.51
mixed mullerian tumor cell line:HTMMT	10689-109F5	30.69	8.81	3.26	3.59	2.61	5.55	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	62.52	14.20	2.97	8.90	2.33	3.81	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	97.67	22.81	25.11	8.52	5.07	1.84	1.38
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	40.34	20.93	10.09	1.52	2.28	2.66	0.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	133.97	90.73	6.28	8.32	8.32	7.39	7.95
myeloma cell line:PCM6	10474-106I6	86.78	19.37	3.76	3.56	0.79	3.56	2.57
myxofibrosarcoma cell line:MFH-ino	10600-108E6	203.93	63.92	2.54	8.62	5.58	1.52	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	67.67	15.69	0.98	4.32	1.96	2.16	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	17.61	7.69	0.89	0.89	2.67	0.11	1.89
nasal epithelial cells, donor1, tech_rep2	12226-129F3	13.75	9.12	1.62	0.59	3.09	0.37	1.76
nasal epithelial cells, donor2	12227-129F4	65.69	19.87	3.86	2.76	2.76	1.10	1.10
neuroblastoma cell line:CHP-134	10508-107D4	334.05	34.05	1.15	9.89	0.92	4.37	7.82
neuroblastoma cell line:NB-1	10539-107G8	187.09	24.88	7.67	12.91	5.05	6.17	9.54
neuroblastoma cell line:NBsusSR	10607-108F4	67.70	25.10	15.61	6.12	6.12	3.59	4.43
neuroblastoma cell line:NH-12	10555-107I6	233.50	37.08	4.85	7.83	2.42	4.66	12.86
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	99.40	54.32	4.27	0.95	1.42	10.91	5.46
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	80.93	32.63	13.15	5.07	6.34	5.23	3.33
neuroectodermal tumor cell line:TASK1	10774-110F9	68.43	13.28	2.42	5.43	2.01	4.63	3.62
neuroepithelioma cell line:SK-N-MC	10728-110A8	148.77	71.84	5.72	6.99	6.36	4.45	3.81
neurofibroma cell line:Hs 53.T	10729-110A9	46.85	7.98	5.86	5.06	1.86	1.06	0.53
neutrophil PMN, donor1	12133-128D9	193.37	29.75	0.00	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	79.68	66.40	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	56.82	18.94	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	156.27	57.33	8.46	10.99	8.12	9.13	20.13
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	109.67	22.41	1.60	4.00	0.80	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	37.19	7.37	3.21	3.53	1.60	4.17	2.24
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	37.31	10.25	7.88	0.79	1.58	1.31	0.00
nucleus accumbens, adult, pool1	10037-101F1	87.18	10.31	1.22	3.19	0.75	1.31	0.66
occipital cortex - adult, donor10196	10172-103C1	51.51	12.36	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	103.86	26.84	0.54	2.68	0.00	1.61	1.07
occipital cortex, newborn, donor10223	10355-105E4	40.40	18.20	0.73	0.73	1.09	0.73	0.73
occipital lobe, adult, donor1	10076-102A4	70.59	13.12	0.52	2.62	0.00	1.84	0.79
occipital lobe, fetal, donor1	10073-102A1	155.33	33.04	0.00	4.72	0.86	15.45	1.72
occipital pole, adult, pool1	10036-101E9	91.93	10.64	0.47	2.92	0.55	0.71	0.87
olfactory region, adult	10195-103E6	59.61	17.39	0.38	2.10	0.19	2.29	0.38
optic nerve, donor1	10277-104E7	136.07	34.02	2.00	0.00	0.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	35.54	15.38	5.35	1.59	3.08	1.03	2.96
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	64.16	12.64	1.24	1.37	3.16	1.79	9.34
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	72.47	25.74	6.60	3.05	2.88	2.20	1.35
oral squamous cell carcinoma cell line:SAS	10544-107H4	60.30	20.91	5.08	2.43	3.70	2.31	1.73
osteoclastoma cell line:Hs 706.T	10704-109H2	47.33	16.17	3.23	3.53	2.35	2.35	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	188.74	51.39	6.54	17.75	4.67	0.93	5.61
osteosarcoma cell line:HS-Os-1	10558-107I9	43.05	11.66	5.73	3.18	1.91	2.33	2.12
ovary, adult, pool1	10020-101D2	101.50	17.65	2.18	4.02	0.61	1.57	2.62
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	68.56	6.05	4.03	7.70	1.83	3.67	1.10
pancreas, adult, donor1	10049-101G4	88.42	25.40	2.82	0.94	0.00	0.94	4.70
pancreatic carcinoma cell line:NOR-P1	10698-109G5	21.80	21.24	1.96	0.84	1.96	2.24	3.91
papillary adenocarcinoma cell line:8505C	10437-106E5	52.47	20.61	10.05	6.64	4.26	4.77	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	87.92	20.86	23.35	5.30	2.65	1.99	5.46
paracentral gyrus, adult, pool1	10035-101E8	67.63	9.52	0.46	2.75	0.55	0.64	0.92
parietal cortex, adult, donor10258	10373-105G4	51.38	19.08	0.73	2.94	0.73	2.94	0.73
parietal lobe - adult, donor10196	10171-103B9	47.96	14.11	0.00	0.00	1.88	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	71.26	18.24	0.29	2.57	0.57	3.14	0.29
parietal lobe, adult, pool1	10034-101E7	78.69	8.02	0.62	3.17	0.26	0.88	0.35
parietal lobe, fetal, donor1	10072-101I9	133.84	34.91	0.97	5.82	0.00	22.31	2.91
parietal lobe, newborn, donor10223	10356-105E5	42.99	22.43	1.12	1.50	0.37	0.37	0.00
parotid gland, adult	10199-103F1	116.55	45.02	2.47	0.00	1.85	1.85	0.00
penis, adult	10200-103F2	90.23	23.63	1.61	2.69	0.00	10.74	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	42.21	29.19	2.23	1.30	1.67	1.86	4.46
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	38.46	14.13	3.79	2.19	1.46	2.33	1.46
pineal gland - adult, donor10196	10179-103C8	63.21	7.10	4.52	9.03	0.00	1.29	0.00
pineal gland, adult, donor10252	10160-103A7	103.04	11.25	2.96	7.11	0.00	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	62.71	13.80	0.63	2.51	0.63	1.25	0.00
pituitary gland - adult, donor10196	10180-103C9	78.92	21.25	7.08	3.04	2.02	3.04	1.01
pituitary gland, adult, donor10252	10162-103A9	108.41	27.10	6.78	3.65	2.08	3.13	5.21
pituitary gland, adult, donor10258	10378-105G9	82.57	12.77	2.55	2.55	0.00	2.55	1.70
placenta, adult, pool1	10021-101D3	44.83	23.97	1.94	0.54	0.65	0.75	2.15
plasma cell leukemia cell line:ARH-77	10840-111E3	56.68	45.03	4.63	2.91	3.05	3.18	1.06
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	74.40	12.30	3.89	5.76	0.93	1.56	1.40
pons, adult, pool1	10033-101E6	59.56	6.46	0.34	2.41	0.26	0.69	0.52
postcentral gyrus, adult, pool1	10032-101E5	77.41	13.43	0.52	2.62	0.17	0.52	0.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	161.04	41.83	0.00	35.55	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	27.54	0.00	11.02	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	0.00	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	98.61	31.61	3.79	7.28	7.57	8.74	3.20
prostate cancer cell line:PC-3	10439-106E7	99.64	12.71	11.07	8.17	4.90	5.99	3.63
prostate, adult, pool1	10022-101D4	93.78	12.79	2.00	2.90	1.00	0.82	2.36
putamen, adult, donor10196	10176-103C5	68.22	17.23	0.24	2.12	0.47	1.42	0.24
putamen, adult, donor10252	10152-102I8	49.02	17.65	0.00	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	25.13	14.21	2.19	1.09	6.56	2.19	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	49.29	11.36	0.48	1.21	0.97	1.45	0.24
putamen, newborn, donor10223	10365-105F5	43.48	23.99	0.75	1.50	0.75	1.50	3.00
rectal cancer cell line:TT1TKB	10469-106I1	51.50	18.04	4.36	4.36	1.45	1.75	5.82
rectum, fetal, donor1	10067-101I4	127.97	22.26	4.17	9.74	1.39	4.17	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	51.30	10.81	8.27	2.12	2.97	1.91	1.70
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	36.86	8.28	4.14	2.90	0.00	4.97	1.66
retina, adult, pool1	10030-101E3	118.09	15.11	3.38	6.66	0.60	1.09	3.28
retinoblastoma cell line:Y79	10475-106I7	140.29	18.97	5.72	17.41	4.94	9.09	15.07
rhabdomyosarcoma cell line:KYM-1	10787-110H4	72.17	20.78	5.29	3.81	3.81	2.70	4.30
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	435.30	79.58	19.97	20.53	8.72	4.50	24.75
sacrococcigeal teratoma cell line:HTST	10695-109G2	120.50	15.91	9.85	3.79	1.52	2.27	2.27
salivary acinar cells, donor1	11771-123I7	41.27	9.55	7.93	2.59	0.97	2.43	0.81
salivary acinar cells, donor2	11772-123I8	56.31	13.22	5.09	2.48	0.83	2.75	0.83
salivary acinar cells, donor3	11773-123I9	96.66	18.54	3.31	4.63	0.00	0.66	0.66
salivary gland, adult, pool1	10093-102C3	109.81	33.17	2.86	1.14	0.00	0.57	6.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	24.28	8.01	6.49	1.60	1.77	1.77	1.69
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	22.10	7.76	6.00	2.47	2.23	1.41	1.65
seminal vesicle, adult	10201-103F3	107.40	17.46	3.70	2.65	1.06	4.23	2.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	35.22	6.80	8.02	0.73	1.94	2.19	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	33.22	15.10	4.78	0.75	0.75	1.51	2.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	61.22	28.10	10.04	1.00	6.02	8.03	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	113.37	17.46	6.31	3.36	2.01	4.43	5.78
signet ring carcinoma cell line:Kato III	10436-106E4	33.93	7.29	8.84	1.88	2.10	1.22	2.10
signet ring carcinoma cell line:NUGC-4	10483-107A6	50.45	25.16	6.19	2.06	2.84	1.68	3.35
skeletal muscle - soleus muscle, donor1	10282-104F3	97.89	14.90	1.42	2.13	0.00	2.13	1.42
skeletal muscle, adult, pool1	10023-101D5	121.86	19.91	1.56	3.12	0.36	0.36	1.56
skeletal muscle, fetal, donor1	10066-101I3	92.46	23.12	1.01	4.02	3.02	6.03	3.02
skin, adult, donor1	10074-102A2	40.71	27.14	0.00	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	113.62	28.41	1.89	3.79	0.00	5.05	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	74.04	14.01	13.01	7.34	2.67	4.67	3.34
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	177.78	46.02	13.24	15.45	6.93	17.34	8.51
small cell lung carcinoma cell line:DMS 144	10841-111E4	53.39	74.02	2.31	0.39	7.13	4.82	13.30
small cell lung carcinoma cell line:LK-2	10541-107H1	70.38	29.17	11.54	3.46	10.38	3.46	7.75
small cell lung carcinoma cell line:NCI-H82	10842-111E5	141.07	27.18	0.48	7.88	7.88	6.43	14.96
small cell lung carcinoma cell line:WA-hT	10562-108A4	113.10	14.38	6.54	8.50	1.74	3.49	4.36
small intestine, adult, pool1	10024-101D6	83.85	28.43	3.22	3.58	0.72	2.15	1.91
small intestine, fetal, donor1	10064-101I1	55.28	18.18	2.95	1.97	0.25	8.85	1.72
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	98.99	33.34	7.69	3.59	1.03	4.62	4.62
smooth muscle, adult, pool1	10048-101G3	123.02	13.18	0.78	2.07	0.52	3.62	2.07
somatostatinoma cell line:QGP-1	10781-110G7	76.12	8.84	6.70	5.36	1.34	1.88	5.36
spinal cord - adult, donor10196	10181-103D1	65.38	12.16	0.46	0.92	0.23	2.52	0.23
spinal cord, adult, donor10252	10159-103A6	88.71	19.32	0.00	6.31	0.00	1.18	2.37
spinal cord, adult, donor10258	10369-105F9	41.51	12.45	0.00	1.38	1.38	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	92.09	28.66	0.61	3.66	0.00	6.10	1.83
spinal cord, newborn, donor10223	10359-105E8	64.75	31.69	0.46	1.84	0.46	1.38	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	45.25	10.45	5.97	5.68	2.84	2.84	0.30
spleen, adult, pool1	10025-101D7	71.48	25.99	3.74	2.42	1.10	1.21	1.21
spleen, fetal, pool1	10044-101F8	93.92	35.12	2.46	3.42	1.19	1.19	3.65
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	79.70	27.22	4.55	1.76	2.79	2.59	3.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	49.37	10.44	1.33	0.76	0.95	0.95	2.09
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	89.46	69.54	2.10	5.24	6.29	12.93	3.84
squamous cell carcinoma cell line:T3M-5	10616-108G4	43.00	13.68	5.08	5.86	4.30	1.17	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	143.06	24.43	6.53	8.89	3.38	6.53	5.40
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	103.36	33.46	4.24	2.12	3.39	2.97	3.39
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	50.77	48.23	8.88	2.54	4.23	1.69	0.85
stomach, fetal, donor1	10062-101H8	131.36	24.56	2.14	3.20	0.00	2.14	0.00
submaxillary gland, adult	10202-103F4	94.57	27.91	1.14	3.42	0.57	0.00	1.71
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	54.27	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	95.54	13.71	0.21	3.53	0.21	2.70	0.62
substantia nigra, adult, donor10258	10371-105G2	40.35	10.86	0.00	1.03	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	52.99	11.31	1.41	1.41	0.00	4.24	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	107.75	40.12	12.15	4.36	5.04	6.42	9.40
temporal lobe, adult, pool1	10031-101E4	84.94	14.75	0.51	3.39	0.17	0.59	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	173.79	49.15	0.00	3.56	0.71	13.53	4.99
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	172.30	48.35	2.64	5.71	0.88	7.91	2.20
tenocyte, donor1	11763-123H8	49.57	17.11	3.84	2.09	1.05	6.28	0.00
tenocyte, donor2	11765-123I1	36.24	12.21	3.82	2.29	1.53	2.67	0.00
tenocyte, donor3	11768-123I4	37.07	12.60	3.34	2.59	1.48	5.56	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	37.22	22.94	9.01	2.89	7.14	4.08	9.52
teratocarcinoma cell line:NCR-G1	10798-110I6	58.11	9.71	8.17	4.93	2.77	4.01	5.24
teratocarcinoma cell line:PA-1	10807-111A6	68.97	24.18	1.70	5.42	6.20	4.03	11.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	44.81	33.89	3.17	2.92	3.43	3.43	6.60
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	52.94	30.25	7.19	0.76	5.67	3.03	10.21
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	20.18	14.07	5.89	0.98	2.40	1.09	4.69
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	49.18	34.85	4.89	2.61	1.63	5.86	9.77
testis, adult, pool1	10026-101D8	88.05	38.22	3.22	3.97	1.07	4.62	1.18
testis, adult, pool2	10096-102C6	110.06	119.99	1.80	8.12	2.71	8.57	0.90
thalamus - adult, donor10196	10168-103B6	72.86	13.25	1.10	2.21	0.00	3.31	1.10
thalamus, adult, donor10252	10154-103A1	115.02	15.32	0.47	2.97	0.94	1.41	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	38.49	10.78	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	31.29	5.27	0.33	1.15	0.66	4.28	0.49
thalamus, newborn, donor10223	10366-105F6	20.71	8.63	1.15	0.00	0.58	1.73	1.15
throat, adult	10209-103G2	84.14	30.46	0.75	2.75	1.00	1.75	0.75
throat, fetal, donor1	10061-101H7	107.26	22.85	3.05	4.27	0.00	5.79	3.96
thymic carcinoma cell line:Ty-82	10803-111A2	65.38	26.23	4.77	2.19	4.97	2.19	1.79
thymus, adult, pool1	10027-101D9	187.79	53.49	7.26	6.56	5.57	4.67	6.46
thymus, fetal, pool1	10043-101F7	129.98	33.35	7.48	7.48	3.43	3.01	5.09
thyroid carcinoma cell line:KHM-5M	10776-110G2	65.15	23.14	5.32	4.12	4.52	4.65	1.33
thyroid carcinoma cell line:TCO-1	10783-110G9	80.04	15.65	10.90	10.34	9.36	4.05	4.89
thyroid, adult, pool1	10028-101E1	103.30	19.50	3.55	2.43	1.03	1.87	2.52
thyroid, fetal, donor1	10060-101H6	87.27	19.25	1.05	4.22	0.26	4.75	2.11
tongue epidermis (fungiform papillae), donor1	10288-104F9	138.58	9.24	0.00	9.24	0.00	3.08	0.00
tongue, adult	10203-103F5	76.52	32.56	3.02	2.56	1.40	3.02	1.16
tongue, fetal, donor1	10059-101H5	74.48	16.95	3.15	4.73	0.79	2.76	2.36
tonsil, adult, pool1	10047-101G2	120.61	32.06	7.11	3.51	1.80	0.90	3.71
trachea, adult, pool1	10029-101E2	65.68	16.69	5.40	2.21	0.65	0.49	1.23
trachea, fetal, donor1	10058-101H4	85.40	25.77	3.46	3.85	0.00	2.69	2.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	54.20	9.57	7.44	4.61	2.48	3.90	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	125.02	19.25	14.89	13.88	4.36	2.43	4.36
transitional-cell carcinoma cell line:JMSU1	10492-107B6	48.57	21.94	13.63	2.98	5.17	5.64	4.23
tridermal teratoma cell line:HGRT	10694-109G1	167.42	39.95	11.42	17.12	1.90	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	33.78	9.40	6.52	3.13	1.78	1.78	3.81
umbilical cord, fetal, donor1	10057-101H3	47.99	22.95	2.09	0.00	0.00	6.26	0.00
uterus, adult, pool1	10100-102D1	155.27	19.79	3.41	4.27	1.19	1.02	6.65
uterus, fetal, donor1	10055-101H1	106.99	25.08	2.56	7.17	0.51	5.63	5.63
vagina, adult	10204-103F6	86.59	25.20	1.29	0.65	0.00	0.65	1.94
vein, adult	10191-103E2	88.99	34.41	1.97	1.97	1.32	1.75	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	43.26	18.69	6.14	1.60	2.67	1.60	2.40